Frequencies for first 10,000 rows of pt variable in reac2006q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 4 0.04 0.04 ABDOMINAL BRUIT | 1 0.01 0.05 ABDOMINAL DISCOMFORT | 8 0.08 0.13 ABDOMINAL DISTENSION | 6 0.06 0.19 ABDOMINAL HERNIA | 3 0.03 0.22 ABDOMINAL PAIN | 41 0.41 0.63 ABDOMINAL PAIN LOWER | 1 0.01 0.64 ABDOMINAL PAIN UPPER | 21 0.21 0.85 ABNORMAL BEHAVIOUR | 9 0.09 0.94 ABNORMAL DREAMS | 2 0.02 0.96 ABNORMAL FAECES | 1 0.01 0.97 ABNORMAL SENSATION IN EYE | 1 0.01 0.98 ABNORMAL SLEEP-RELATED EVENT | 1 0.01 0.99 ABORTION INDUCED | 1 0.01 1.00 ABORTION SPONTANEOUS | 3 0.03 1.03 ABORTION THREATENED | 1 0.01 1.04 ABSCESS | 1 0.01 1.05 ABSCESS JAW | 2 0.02 1.07 ABSCESS NECK | 1 0.01 1.08 ACANTHOSIS | 1 0.01 1.09 ACCELERATED HYPERTENSION | 1 0.01 1.10 ACCIDENT AT WORK | 1 0.01 1.11 ACCIDENTAL DRUG INTAKE BY CHILD | 2 0.02 1.13 ACCIDENTAL EXPOSURE | 4 0.04 1.17 ACCIDENTAL NEEDLE STICK | 1 0.01 1.18 ACCIDENTAL OVERDOSE | 5 0.05 1.23 ACETONAEMIC VOMITING | 1 0.01 1.24 ACIDOSIS | 1 0.01 1.25 ACTINIC KERATOSIS | 3 0.03 1.28 ACTINOMYCOSIS | 1 0.01 1.29 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 1.32 ACTIVATED PROTEIN C RESISTANCE | 1 0.01 1.33 ACTIVITIES OF DAILY LIVING IMPAIRED | 8 0.08 1.41 ACUTE CORONARY SYNDROME | 7 0.07 1.48 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 1.49 ACUTE MYELOID LEUKAEMIA | 1 0.01 1.50 ACUTE MYOCARDIAL INFARCTION | 54 0.54 2.04 ACUTE PSYCHOSIS | 1 0.01 2.05 ACUTE PULMONARY OEDEMA | 2 0.02 2.07 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.10 ACUTE RESPIRATORY FAILURE | 1 0.01 2.11 ACUTE SINUSITIS | 2 0.02 2.13 ADENOIDECTOMY | 2 0.02 2.15 ADENOMA BENIGN | 1 0.01 2.16 ADENOVIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 2.17 ADENOVIRUS INFECTION | 1 0.01 2.18 ADHESION | 2 0.02 2.20 ADRENAL CORTICAL INSUFFICIENCY | 1 0.01 2.21 ADRENAL HAEMORRHAGE | 1 0.01 2.22 ADRENAL INSUFFICIENCY | 2 0.02 2.24 ADRENAL SUPPRESSION | 1 0.01 2.25 ADVERSE DRUG REACTION | 1 0.01 2.26 ADVERSE EVENT | 33 0.33 2.59 AFFECT LABILITY | 1 0.01 2.60 AFFECTIVE DISORDER | 1 0.01 2.61 AGEUSIA | 2 0.02 2.63 AGGRESSION | 12 0.12 2.75 AGITATION | 6 0.06 2.81 AGORAPHOBIA | 2 0.02 2.83 AGRANULOCYTOSIS | 11 0.11 2.94 AIR EMBOLISM | 1 0.01 2.95 AKATHISIA | 2 0.02 2.97 AKINESIA | 1 0.01 2.98 ALANINE AMINOTRANSFERASE INCREASED | 44 0.44 3.42 ALCOHOL INTERACTION | 1 0.01 3.43 ALCOHOL POISONING | 1 0.01 3.44 ALCOHOL USE | 1 0.01 3.45 ALCOHOLIC | 1 0.01 3.46 ALCOHOLISM | 2 0.02 3.48 ALDOLASE INCREASED | 2 0.02 3.50 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.51 ALOPECIA | 8 0.08 3.59 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.60 ALVEOLITIS ALLERGIC | 3 0.03 3.63 ALVEOLOPLASTY | 1 0.01 3.64 AMAUROSIS FUGAX | 1 0.01 3.65 AMBLYOPIA | 1 0.01 3.66 AMENORRHOEA | 1 0.01 3.67 AMNESIA | 19 0.19 3.86 AMNIOTIC FLUID VOLUME DECREASED | 1 0.01 3.87 AMPUTATION | 1 0.01 3.88 ANAEMIA | 55 0.55 4.43 ANAEMIA MACROCYTIC | 3 0.03 4.46 ANAEMIA OF CHRONIC DISEASE | 2 0.02 4.48 ANAEMIA POSTOPERATIVE | 3 0.03 4.51 ANAL CANDIDIASIS | 1 0.01 4.52 ANAL FISSURE | 2 0.02 4.54 ANAL FISTULA | 1 0.01 4.55 ANAL HAEMORRHAGE | 1 0.01 4.56 ANAL SPHINCTER ATONY | 1 0.01 4.57 ANAPHYLACTIC REACTION | 3 0.03 4.60 ANAPHYLACTIC SHOCK | 3 0.03 4.63 ANAPHYLACTOID SHOCK | 1 0.01 4.64 ANEURYSM | 5 0.05 4.69 ANGER | 3 0.03 4.72 ANGINA PECTORIS | 57 0.57 5.29 ANGINA UNSTABLE | 25 0.25 5.54 ANGIONEUROTIC OEDEMA | 2 0.02 5.56 ANGIOPATHY | 3 0.03 5.59 ANGIOPLASTY | 1 0.01 5.60 ANHEDONIA | 6 0.06 5.66 ANIMAL BITE | 1 0.01 5.67 ANION GAP INCREASED | 1 0.01 5.68 ANISOCYTOSIS | 1 0.01 5.69 ANKLE FRACTURE | 2 0.02 5.71 ANKYLOSING SPONDYLITIS | 1 0.01 5.72 ANORECTAL CELLULITIS | 1 0.01 5.73 ANORECTAL DISORDER | 2 0.02 5.75 ANOREXIA | 16 0.16 5.91 ANOSMIA | 2 0.02 5.93 ANOTIA | 1 0.01 5.94 ANOXIC ENCEPHALOPATHY | 1 0.01 5.95 ANTI FACTOR IX ANTIBODY POSITIVE | 1 0.01 5.96 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 2 0.02 5.98 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC | 1 0.01 5.99 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 6.00 ANTINUCLEAR ANTIBODY INCREASED | 1 0.01 6.01 ANTINUCLEAR ANTIBODY POSITIVE | 6 0.06 6.07 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 6.08 ANURIA | 5 0.05 6.13 ANXIETY | 86 0.86 6.99 ANXIETY DISORDER | 2 0.02 7.01 ANXIETY DISORDER DUE TO A GENERAL MED.. | 1 0.01 7.02 AORTIC ANEURYSM | 6 0.06 7.08 AORTIC ANEURYSM REPAIR | 1 0.01 7.09 AORTIC ARTERIOSCLEROSIS | 6 0.06 7.15 AORTIC CALCIFICATION | 1 0.01 7.16 AORTIC DILATATION | 1 0.01 7.17 AORTIC DISSECTION | 1 0.01 7.18 AORTIC THROMBOSIS | 2 0.02 7.20 AORTIC VALVE CALCIFICATION | 1 0.01 7.21 AORTIC VALVE INCOMPETENCE | 7 0.07 7.28 AORTIC VALVE SCLEROSIS | 2 0.02 7.30 AORTIC VALVE STENOSIS | 5 0.05 7.35 APALLIC SYNDROME | 2 0.02 7.37 APATHY | 2 0.02 7.39 APGAR SCORE LOW | 1 0.01 7.40 APHAGIA | 1 0.01 7.41 APHASIA | 6 0.06 7.47 APHTHOUS STOMATITIS | 2 0.02 7.49 APLASIA PURE RED CELL | 4 0.04 7.53 APNOEA | 3 0.03 7.56 APNOEA TEST | 1 0.01 7.57 APNOEIC ATTACK | 1 0.01 7.58 APPENDICECTOMY | 1 0.01 7.59 APPENDICITIS PERFORATED | 1 0.01 7.60 APPLICATION SITE PAIN | 2 0.02 7.62 APPLICATION SITE REACTION | 1 0.01 7.63 ARACHNOID CYST | 1 0.01 7.64 AREFLEXIA | 1 0.01 7.65 ARRHYTHMIA | 22 0.22 7.87 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 7.89 ARTERIAL BYPASS OPERATION | 1 0.01 7.90 ARTERIAL INJURY | 2 0.02 7.92 ARTERIAL INSUFFICIENCY | 2 0.02 7.94 ARTERIAL OCCLUSIVE DISEASE | 11 0.11 8.05 ARTERIAL REPAIR | 1 0.01 8.06 ARTERIAL SPASM | 1 0.01 8.07 ARTERIAL STENT INSERTION | 1 0.01 8.08 ARTERIAL THROMBOSIS | 1 0.01 8.09 ARTERIOSCLEROSIS | 30 0.30 8.39 ARTERIOSCLEROSIS CORONARY ARTERY | 19 0.19 8.58 ARTERIOSPASM CORONARY | 1 0.01 8.59 ARTERIOVENOUS GRAFT THROMBOSIS | 1 0.01 8.60 ARTERIOVENOUS MALFORMATION | 1 0.01 8.61 ARTERY DISSECTION | 1 0.01 8.62 ARTHRALGIA | 47 0.47 9.09 ARTHRITIS | 10 0.10 9.19 ARTHROPATHY | 42 0.42 9.61 ARTHROPOD BITE | 4 0.04 9.65 ARTHROPOD STING | 1 0.01 9.66 ASBESTOSIS | 1 0.01 9.67 ASCITES | 7 0.07 9.74 ASPARTATE AMINOTRANSFERASE | 1 0.01 9.75 ASPARTATE AMINOTRANSFERASE INCREASED | 40 0.40 10.15 ASPIRATION | 3 0.03 10.18 ASPIRATION BIOPSY | 1 0.01 10.19 ASTERIXIS | 1 0.01 10.20 ASTHENIA | 51 0.51 10.71 ASTHMA | 22 0.22 10.93 ASTHMA LATE ONSET | 1 0.01 10.94 ATELECTASIS | 10 0.10 11.04 ATRIAL FIBRILLATION | 39 0.39 11.43 ATRIAL FLUTTER | 1 0.01 11.44 ATRIAL SEPTAL DEFECT | 2 0.02 11.46 ATRIAL THROMBOSIS | 2 0.02 11.48 ATRIOVENTRICULAR BLOCK | 1 0.01 11.49 ATRIOVENTRICULAR SEPTAL DEFECT | 1 0.01 11.50 ATROPHIC VULVOVAGINITIS | 1 0.01 11.51 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 11.52 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 11.53 AUTOIMMUNE DISORDER | 3 0.03 11.56 AUTOIMMUNE HEPATITIS | 1 0.01 11.57 AXILLARY PAIN | 1 0.01 11.58 AZOOSPERMIA | 1 0.01 11.59 BACK DISORDER | 23 0.23 11.82 BACK INJURY | 21 0.21 12.03 BACK PAIN | 59 0.59 12.62 BACTERAEMIA | 4 0.04 12.66 BACTERIA STOOL IDENTIFIED | 1 0.01 12.67 BACTERIAL INFECTION | 8 0.08 12.75 BACTERIAL SEPSIS | 1 0.01 12.76 BALANCE DISORDER | 7 0.07 12.83 BALANITIS CANDIDA | 1 0.01 12.84 BASAL CELL CARCINOMA | 2 0.02 12.86 BASE EXCESS INCREASED | 1 0.01 12.87 BASILAR ARTERY THROMBOSIS | 1 0.01 12.88 BENIGN NEOPLASM | 1 0.01 12.89 BENIGN NEOPLASM OF EPIDIDYMIS | 1 0.01 12.90 BENIGN PROSTATIC HYPERPLASIA | 7 0.07 12.97 BICUSPID AORTIC VALVE | 1 0.01 12.98 BILE DUCT CANCER | 1 0.01 12.99 BILE DUCT STENOSIS | 1 0.01 13.00 BILE DUCT STONE | 1 0.01 13.01 BILIARY COLIC | 1 0.01 13.02 BIOPSY BONE MARROW ABNORMAL | 1 0.01 13.03 BIOPSY BREAST | 1 0.01 13.04 BIOPSY TONGUE NORMAL | 1 0.01 13.05 BIPOLAR DISORDER | 3 0.03 13.08 BK VIRUS INFECTION | 1 0.01 13.09 BLADDER CANCER | 1 0.01 13.10 BLADDER DISORDER | 7 0.07 13.17 BLADDER INJURY | 1 0.01 13.18 BLADDER NEOPLASM | 2 0.02 13.20 BLADDER OBSTRUCTION | 2 0.02 13.22 BLADDER PAIN | 1 0.01 13.23 BLAST INJURY | 1 0.01 13.24 BLEEDING TIME PROLONGED | 3 0.03 13.27 BLINDNESS | 8 0.08 13.35 BLINDNESS CORTICAL | 2 0.02 13.37 BLINDNESS TRANSIENT | 2 0.02 13.39 BLINDNESS UNILATERAL | 4 0.04 13.43 BLISTER | 6 0.06 13.49 BLOOD ALBUMIN ABNORMAL | 1 0.01 13.50 BLOOD ALBUMIN DECREASED | 4 0.04 13.54 BLOOD ALBUMIN INCREASED | 1 0.01 13.55 BLOOD ALKALINE PHOSPHATASE INCREASED | 12 0.12 13.67 BLOOD BICARBONATE DECREASED | 3 0.03 13.70 BLOOD BILIRUBIN INCREASED | 15 0.15 13.85 BLOOD BLISTER | 2 0.02 13.87 BLOOD CALCIUM DECREASED | 4 0.04 13.91 BLOOD CALCIUM INCREASED | 1 0.01 13.92 BLOOD CHLORIDE DECREASED | 3 0.03 13.95 BLOOD CHLORIDE INCREASED | 1 0.01 13.96 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 13.97 BLOOD CHOLESTEROL INCREASED | 26 0.26 14.23 BLOOD CORTISOL DECREASED | 1 0.01 14.24 BLOOD CREATINE INCREASED | 1 0.01 14.25 BLOOD CREATINE PHOSPHOKINASE INCREASED | 10 0.10 14.35 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 14.36 BLOOD CREATINE PHOSPHOKINASE MM INCRE.. | 1 0.01 14.37 BLOOD CREATININE ABNORMAL | 1 0.01 14.38 BLOOD CREATININE DECREASED | 1 0.01 14.39 BLOOD CREATININE INCREASED | 25 0.25 14.64 BLOOD CULTURE POSITIVE | 1 0.01 14.65 BLOOD DISORDER | 2 0.02 14.67 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 14.68 BLOOD ELECTROLYTES DECREASED | 1 0.01 14.69 BLOOD GLUCOSE ABNORMAL | 5 0.05 14.74 BLOOD GLUCOSE DECREASED | 6 0.06 14.80 BLOOD GLUCOSE INCREASED | 22 0.22 15.02 BLOOD HOMOCYSTEINE INCREASED | 2 0.02 15.04 BLOOD IMMUNOGLOBULIN G DECREASED | 2 0.02 15.06 BLOOD IMMUNOGLOBULIN M DECREASED | 1 0.01 15.07 BLOOD IMMUNOGLOBULIN M INCREASED | 1 0.01 15.08 BLOOD IRON ABNORMAL | 1 0.01 15.09 BLOOD IRON INCREASED | 1 0.01 15.10 BLOOD LACTATE DEHYDROGENASE INCREASED | 8 0.08 15.18 BLOOD MAGNESIUM DECREASED | 1 0.01 15.19 BLOOD MAGNESIUM INCREASED | 1 0.01 15.20 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 15.21 BLOOD PH DECREASED | 1 0.01 15.22 BLOOD PHOSPHORUS DECREASED | 2 0.02 15.24 BLOOD PHOSPHORUS INCREASED | 2 0.02 15.26 BLOOD POTASSIUM DECREASED | 6 0.06 15.32 BLOOD POTASSIUM INCREASED | 5 0.05 15.37 BLOOD PRESSURE ABNORMAL | 4 0.04 15.41 BLOOD PRESSURE DECREASED | 6 0.06 15.47 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 15.48 BLOOD PRESSURE FLUCTUATION | 9 0.09 15.57 BLOOD PRESSURE INADEQUATELY CONTROLLED | 3 0.03 15.60 BLOOD PRESSURE INCREASED | 27 0.27 15.87 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 15.89 BLOOD PRESSURE SYSTOLIC INCREASED | 2 0.02 15.91 BLOOD PRODUCT TRANSFUSION | 1 0.01 15.92 BLOOD SODIUM DECREASED | 7 0.07 15.99 BLOOD SODIUM INCREASED | 1 0.01 16.00 BLOOD TESTOSTERONE DECREASED | 1 0.01 16.01 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 16.02 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 16.03 BLOOD TRIGLYCERIDES INCREASED | 10 0.10 16.13 BLOOD UREA ABNORMAL | 1 0.01 16.14 BLOOD UREA INCREASED | 12 0.12 16.26 BLOOD URINE | 1 0.01 16.27 BLOOD URINE PRESENT | 3 0.03 16.30 BODY HEIGHT DECREASED | 1 0.01 16.31 BODY TEMPERATURE INCREASED | 3 0.03 16.34 BONE DEBRIDEMENT | 2 0.02 16.36 BONE DISORDER | 13 0.13 16.49 BONE MARROW FAILURE | 5 0.05 16.54 BONE MARROW TOXICITY | 1 0.01 16.55 BONE PAIN | 2 0.02 16.57 BONE SCAN ABNORMAL | 1 0.01 16.58 BONE TRIMMING | 1 0.01 16.59 BOWEL MOVEMENT IRREGULARITY | 1 0.01 16.60 BOWEL SOUNDS ABNORMAL | 1 0.01 16.61 BRADYARRHYTHMIA | 1 0.01 16.62 BRADYCARDIA | 17 0.17 16.79 BRADYCARDIA NEONATAL | 2 0.02 16.81 BRADYPHRENIA | 1 0.01 16.82 BRAIN ABSCESS | 1 0.01 16.83 BRAIN DAMAGE | 1 0.01 16.84 BRAIN DEATH | 1 0.01 16.85 BRAIN HERNIATION | 1 0.01 16.86 BRAIN NATRIURETIC PEPTIDE ABNORMAL | 1 0.01 16.87 BRAIN NEOPLASM | 1 0.01 16.88 BRAIN OEDEMA | 8 0.08 16.96 BRAIN STEM AUDITORY EVOKED RESPONSE A.. | 1 0.01 16.97 BRAIN STEM INFARCTION | 3 0.03 17.00 BREAKTHROUGH PAIN | 1 0.01 17.01 BREAST CANCER | 17 0.17 17.18 BREAST CANCER FEMALE | 1 0.01 17.19 BREAST CANCER STAGE I | 2 0.02 17.21 BREAST CYST | 1 0.01 17.22 BREAST DISORDER | 2 0.02 17.24 BREAST MASS | 6 0.06 17.30 BREAST MICROCALCIFICATION | 1 0.01 17.31 BREAST PAIN | 1 0.01 17.32 BREAST SWELLING | 2 0.02 17.34 BREATH SOUNDS ABNORMAL | 1 0.01 17.35 BRONCHIAL FISTULA | 3 0.03 17.38 BRONCHIAL HYPERACTIVITY | 3 0.03 17.41 BRONCHIAL OBSTRUCTION | 2 0.02 17.43 BRONCHIECTASIS | 2 0.02 17.45 BRONCHITIS | 22 0.22 17.67 BRONCHITIS ACUTE | 3 0.03 17.70 BRONCHITIS CHRONIC | 1 0.01 17.71 BRONCHOPNEUMONIA | 3 0.03 17.74 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 17.75 BRONCHOSCOPY ABNORMAL | 1 0.01 17.76 BRONCHOSPASM | 5 0.05 17.81 BRUXISM | 2 0.02 17.83 BUNDLE BRANCH BLOCK LEFT | 5 0.05 17.88 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 17.90 BURNING SENSATION | 2 0.02 17.92 BURSITIS | 2 0.02 17.94 BUTTOCK PAIN | 1 0.01 17.95 C-REACTIVE PROTEIN INCREASED | 11 0.11 18.06 CACHEXIA | 1 0.01 18.07 CAESAREAN SECTION | 3 0.03 18.10 CALCINOSIS | 2 0.02 18.12 CALCULUS BLADDER | 2 0.02 18.14 CALCULUS URETERIC | 1 0.01 18.15 CAMPYLOBACTER GASTROENTERITIS | 1 0.01 18.16 CANDIDIASIS | 4 0.04 18.20 CARBOHYDRATE ANTIGEN 27.29 INCREASED | 1 0.01 18.21 CARBON DIOXIDE DECREASED | 1 0.01 18.22 CARBON DIOXIDE INCREASED | 1 0.01 18.23 CARDIAC ARREST | 24 0.24 18.47 CARDIAC DISORDER | 89 0.89 19.36 CARDIAC ENZYMES INCREASED | 1 0.01 19.37 CARDIAC FAILURE | 20 0.20 19.57 CARDIAC FAILURE CONGESTIVE | 48 0.48 20.05 CARDIAC FIBRILLATION | 1 0.01 20.06 CARDIAC FLUTTER | 1 0.01 20.07 CARDIAC MURMUR | 15 0.15 20.22 CARDIAC OPERATION | 1 0.01 20.23 CARDIAC PACEMAKER MALFUNCTION | 1 0.01 20.24 CARDIAC TAMPONADE | 1 0.01 20.25 CARDIAC VALVE DISEASE | 4 0.04 20.29 CARDIAC VALVE VEGETATION | 1 0.01 20.30 CARDIO-RESPIRATORY ARREST | 10 0.10 20.40 CARDIOGENIC SHOCK | 4 0.04 20.44 CARDIOMEGALY | 16 0.16 20.60 CARDIOMYOPATHY | 13 0.13 20.73 CARDIOPULMONARY FAILURE | 2 0.02 20.75 CARDIOTOXICITY | 1 0.01 20.76 CARDIOVASCULAR DISORDER | 61 0.61 21.37 CARDIOVASCULAR EVENT PROPHYLAXIS | 1 0.01 21.38 CAROTID ARTERY ATHEROMA | 1 0.01 21.39 CAROTID ARTERY DISEASE | 5 0.05 21.44 CAROTID ARTERY OCCLUSION | 6 0.06 21.50 CAROTID ARTERY STENOSIS | 13 0.13 21.63 CAROTID ARTERY THROMBOSIS | 1 0.01 21.64 CAROTID BRUIT | 6 0.06 21.70 CARPAL TUNNEL SYNDROME | 5 0.05 21.75 CATARACT | 11 0.11 21.86 CATARACT OPERATION | 1 0.01 21.87 CATARACT SUBCAPSULAR | 1 0.01 21.88 CATHETER RELATED COMPLICATION | 1 0.01 21.89 CATHETER RELATED INFECTION | 1 0.01 21.90 CATHETER SITE HAEMATOMA | 1 0.01 21.91 CATHETER SITE HAEMORRHAGE | 2 0.02 21.93 CATHETER SITE RELATED REACTION | 1 0.01 21.94 CATHETERISATION CARDIAC | 2 0.02 21.96 CD4 LYMPHOCYTES DECREASED | 1 0.01 21.97 CD8 LYMPHOCYTES DECREASED | 1 0.01 21.98 CELLULITIS | 11 0.11 22.09 CENTRAL NERVOUS SYSTEM LYMPHOMA | 1 0.01 22.10 CEREBELLAR HAEMORRHAGE | 1 0.01 22.11 CEREBELLAR INFARCTION | 1 0.01 22.12 CEREBELLAR SYNDROME | 1 0.01 22.13 CEREBRAL ARTERIOSCLEROSIS | 1 0.01 22.14 CEREBRAL ARTERY EMBOLISM | 2 0.02 22.16 CEREBRAL ARTERY OCCLUSION | 3 0.03 22.19 CEREBRAL ARTERY STENOSIS | 1 0.01 22.20 CEREBRAL ATROPHY | 2 0.02 22.22 CEREBRAL HAEMORRHAGE | 7 0.07 22.29 CEREBRAL INFARCTION | 18 0.18 22.47 CEREBRAL ISCHAEMIA | 4 0.04 22.51 CEREBROVASCULAR ACCIDENT | 218 2.18 24.69 CEREBROVASCULAR DISORDER | 11 0.11 24.80 CERVICAL MYELOPATHY | 1 0.01 24.81 CERVICITIS | 1 0.01 24.82 CERVICOBRACHIAL SYNDROME | 2 0.02 24.84 CERVIX CARCINOMA | 1 0.01 24.85 CHEILITIS | 1 0.01 24.86 CHEST DISCOMFORT | 20 0.20 25.06 CHEST PAIN | 117 1.17 26.23 CHEST X-RAY ABNORMAL | 3 0.03 26.26 CHILLS | 13 0.13 26.39 CHOKING | 2 0.02 26.41 CHOKING SENSATION | 1 0.01 26.42 CHOLANGITIS | 2 0.02 26.44 CHOLANGITIS ACUTE | 1 0.01 26.45 CHOLECYSTECTOMY | 3 0.03 26.48 CHOLECYSTITIS | 3 0.03 26.51 CHOLECYSTITIS ACUTE | 2 0.02 26.53 CHOLELITHIASIS | 13 0.13 26.66 CHOLESTASIS | 3 0.03 26.69 CHONDROCALCINOSIS | 1 0.01 26.70 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 26.71 CHONDROPATHY | 1 0.01 26.72 CHROMATURIA | 1 0.01 26.73 CHRONIC FATIGUE SYNDROME | 2 0.02 26.75 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 26.76 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 0 | 1 0.01 26.77 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 34 0.34 27.11 CHRONIC SINUSITIS | 2 0.02 27.13 CIRCULATORY COLLAPSE | 4 0.04 27.17 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 2 0.02 27.19 CIRRHOSIS ALCOHOLIC | 1 0.01 27.20 CLAVICLE FRACTURE | 1 0.01 27.21 CLEFT LIP | 1 0.01 27.22 CLEFT PALATE | 1 0.01 27.23 CLONIC CONVULSION | 1 0.01 27.24 CLOSED HEAD INJURY | 1 0.01 27.25 CLOSTRIDIAL INFECTION | 4 0.04 27.29 CLOSTRIDIUM COLITIS | 3 0.03 27.32 CLOSTRIDIUM DIFFICILE TOXIN TEST POSI.. | 1 0.01 27.33 CLUMSINESS | 1 0.01 27.34 COAGULOPATHY | 6 0.06 27.40 COCCYDYNIA | 1 0.01 27.41 COGNITIVE DISORDER | 4 0.04 27.45 COLECTOMY | 2 0.02 27.47 COLITIS | 7 0.07 27.54 COLITIS ISCHAEMIC | 4 0.04 27.58 COLITIS ULCERATIVE | 6 0.06 27.64 COLON ADENOMA | 1 0.01 27.65 COLON CANCER | 1 0.01 27.66 COLON NEOPLASM | 1 0.01 27.67 COLONIC OBSTRUCTION | 1 0.01 27.68 COLONIC POLYP | 5 0.05 27.73 COLONIC STENOSIS | 1 0.01 27.74 COMA | 8 0.08 27.82 COMPLETED SUICIDE | 15 0.15 27.97 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 27.98 COMPRESSION FRACTURE | 2 0.02 28.00 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 28.01 CONCOMITANT DISEASE PROGRESSION | 3 0.03 28.04 CONCUSSION | 3 0.03 28.07 CONDITION AGGRAVATED | 27 0.27 28.34 CONDUCTION DISORDER | 1 0.01 28.35 CONFUSIONAL STATE | 26 0.26 28.61 CONGENITAL APLASTIC ANAEMIA | 1 0.01 28.62 CONGENITAL JAW MALFORMATION | 1 0.01 28.63 CONGESTIVE CARDIOMYOPATHY | 5 0.05 28.68 CONJUNCTIVITIS | 2 0.02 28.70 CONJUNCTIVITIS ALLERGIC | 1 0.01 28.71 CONSTIPATION | 21 0.21 28.92 CONTRACTED BLADDER | 1 0.01 28.93 CONTUSION | 14 0.14 29.07 CONVERSION DISORDER | 1 0.01 29.08 CONVULSION | 40 0.40 29.48 COORDINATION ABNORMAL | 7 0.07 29.55 CORNEAL DISORDER | 1 0.01 29.56 CORONARY ANGIOPLASTY | 1 0.01 29.57 CORONARY ARTERY DISEASE | 106 1.06 30.63 CORONARY ARTERY INSUFFICIENCY | 1 0.01 30.64 CORONARY ARTERY OCCLUSION | 24 0.24 30.88 CORONARY ARTERY RESTENOSIS | 2 0.02 30.90 CORONARY ARTERY STENOSIS | 17 0.17 31.07 CORONARY ARTERY SURGERY | 2 0.02 31.09 CORONARY ARTERY THROMBOSIS | 2 0.02 31.11 CORRECTIVE LENS USER | 1 0.01 31.12 COSTOCHONDRITIS | 2 0.02 31.14 COUGH | 29 0.29 31.43 CRANIAL NERVE PARALYSIS | 1 0.01 31.44 CREATINE PHOSPHOKINASE DECREASED | 1 0.01 31.45 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 31.46 CROHN'S DISEASE | 2 0.02 31.48 CRYING | 5 0.05 31.53 CSF LYMPHOCYTE COUNT ABNORMAL | 1 0.01 31.54 CUBITAL TUNNEL SYNDROME | 1 0.01 31.55 CULTURE THROAT POSITIVE | 1 0.01 31.56 CULTURE URINE POSITIVE | 1 0.01 31.57 CUSHING'S SYNDROME | 1 0.01 31.58 CUSHINGOID | 1 0.01 31.59 CUTANEOUS VASCULITIS | 1 0.01 31.60 CUTIS LAXA | 1 0.01 31.61 CYANOSIS | 7 0.07 31.68 CYANOSIS NEONATAL | 1 0.01 31.69 CYST | 3 0.03 31.72 CYSTIC FIBROSIS | 2 0.02 31.74 CYSTITIS | 3 0.03 31.77 CYSTOCELE | 1 0.01 31.78 CYTOGENETIC ANALYSIS ABNORMAL | 1 0.01 31.79 CYTOLYTIC HEPATITIS | 3 0.03 31.82 CYTOMEGALOVIRUS ANTIBODY POSITIVE | 1 0.01 31.83 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 31.84 CYTOMEGALOVIRUS INFECTION | 3 0.03 31.87 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 31.88 DACRYOSTENOSIS ACQUIRED | 1 0.01 31.89 DEAFNESS | 6 0.06 31.95 DEAFNESS NEUROSENSORY | 1 0.01 31.96 DEAFNESS UNILATERAL | 3 0.03 31.99 DEATH | 72 0.72 32.71 DECREASED ACTIVITY | 1 0.01 32.72 DECREASED APPETITE | 10 0.10 32.82 DECREASED INTEREST | 1 0.01 32.83 DECUBITUS ULCER | 3 0.03 32.86 DEEP VEIN THROMBOSIS | 35 0.35 33.21 DEFORMITY | 1 0.01 33.22 DEHYDRATION | 46 0.46 33.68 DELIRIUM | 9 0.09 33.77 DELUSION | 3 0.03 33.80 DEMENTIA | 2 0.02 33.82 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 33.83 DENTAL CARIES | 1 0.01 33.84 DENTAL OPERATION | 2 0.02 33.86 DENTAL PROSTHESIS PLACEMENT | 1 0.01 33.87 DENTAL TREATMENT | 1 0.01 33.88 DEPOSIT EYE | 1 0.01 33.89 DEPRESSED LEVEL OF CONSCIOUSNESS | 20 0.20 34.09 DEPRESSED MOOD | 2 0.02 34.11 DEPRESSION | 110 1.10 35.21 DEREALISATION | 1 0.01 35.22 DERMAL CYST | 1 0.01 35.23 DERMATITIS | 5 0.05 35.28 DERMATITIS ALLERGIC | 3 0.03 35.31 DERMATITIS ATOPIC | 1 0.01 35.32 DERMATITIS EXFOLIATIVE | 3 0.03 35.35 DERMATITIS PSORIASIFORM | 1 0.01 35.36 DEVICE RELATED INFECTION | 1 0.01 35.37 DIABETES INSIPIDUS | 1 0.01 35.38 DIABETES MELLITUS | 26 0.26 35.64 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 11 0.11 35.75 DIABETIC FOOT | 1 0.01 35.76 DIABETIC KETOACIDOSIS | 2 0.02 35.78 DIABETIC NEPHROPATHY | 1 0.01 35.79 DIABETIC NEUROPATHY | 3 0.03 35.82 DIABETIC ULCER | 2 0.02 35.84 DIALYSIS | 4 0.04 35.88 DIAPHRAGMATIC DISORDER | 2 0.02 35.90 DIARRHOEA | 57 0.57 36.47 DIARRHOEA HAEMORRHAGIC | 1 0.01 36.48 DIASTOLIC DYSFUNCTION | 3 0.03 36.51 DIFFICULTY IN WALKING | 7 0.07 36.58 DILATATION ATRIAL | 7 0.07 36.65 DILATATION VENTRICULAR | 2 0.02 36.67 DIPLOPIA | 7 0.07 36.74 DISABILITY | 2 0.02 36.76 DISCOMFORT | 2 0.02 36.78 DISEASE PROGRESSION | 3 0.03 36.81 DISEASE RECURRENCE | 3 0.03 36.84 DISORIENTATION | 3 0.03 36.87 DISSEMINATED INTRAVASCULAR COAGULATION | 9 0.09 36.96 DISSEMINATED TUBERCULOSIS | 3 0.03 36.99 DISSOCIATIVE DISORDER | 1 0.01 37.00 DISTURBANCE IN ATTENTION | 6 0.06 37.06 DIVERTICULAR HERNIA | 1 0.01 37.07 DIVERTICULAR PERFORATION | 2 0.02 37.09 DIVERTICULITIS | 8 0.08 37.17 DIVERTICULUM | 16 0.16 37.33 DIZZINESS | 60 0.60 37.93 DIZZINESS POSTURAL | 2 0.02 37.95 DNA ANTIBODY POSITIVE | 1 0.01 37.96 DRESSLER'S SYNDROME | 1 0.01 37.97 DROOLING | 2 0.02 37.99 DRUG ABUSER | 4 0.04 38.03 DRUG ADMINISTRATION ERROR | 4 0.04 38.07 DRUG DEPENDENCE | 2 0.02 38.09 DRUG DISPENSING ERROR | 1 0.01 38.10 DRUG DOSE OMISSION | 3 0.03 38.13 DRUG EFFECT DECREASED | 2 0.02 38.15 DRUG EFFECT INCREASED | 1 0.01 38.16 DRUG ERUPTION | 3 0.03 38.19 DRUG EXPOSURE DURING PREGNANCY | 25 0.25 38.44 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 38.45 DRUG HYPERSENSITIVITY | 18 0.18 38.63 DRUG INEFFECTIVE | 25 0.25 38.88 DRUG INTERACTION | 26 0.26 39.14 DRUG INTOLERANCE | 3 0.03 39.17 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 39.18 DRUG LEVEL DECREASED | 1 0.01 39.19 DRUG LEVEL INCREASED | 9 0.09 39.28 DRUG PRESCRIBING ERROR | 1 0.01 39.29 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 1 0.01 39.30 DRUG SCREEN POSITIVE | 2 0.02 39.32 DRUG THERAPY CHANGED | 2 0.02 39.34 DRUG TOXICITY | 2 0.02 39.36 DRUG WITHDRAWAL SYNDROME | 6 0.06 39.42 DRY EYE | 1 0.01 39.43 DRY MOUTH | 6 0.06 39.49 DRY SKIN | 3 0.03 39.52 DRY THROAT | 2 0.02 39.54 DUODENAL ULCER | 3 0.03 39.57 DUODENAL ULCER PERFORATION | 1 0.01 39.58 DUODENITIS | 1 0.01 39.59 DYSARTHRIA | 5 0.05 39.64 DYSENTERY | 1 0.01 39.65 DYSGEUSIA | 6 0.06 39.71 DYSKINESIA | 7 0.07 39.78 DYSKINESIA NEONATAL | 1 0.01 39.79 DYSLALIA | 1 0.01 39.80 DYSLIPIDAEMIA | 15 0.15 39.95 DYSMENORRHOEA | 1 0.01 39.96 DYSPAREUNIA | 1 0.01 39.97 DYSPEPSIA | 17 0.17 40.14 DYSPHAGIA | 9 0.09 40.23 DYSPHASIA | 1 0.01 40.24 DYSPHONIA | 5 0.05 40.29 DYSPLASIA | 1 0.01 40.30 DYSPNOEA | 106 1.06 41.36 DYSPNOEA EXERTIONAL | 9 0.09 41.45 DYSSTASIA | 1 0.01 41.46 DYSTONIA | 2 0.02 41.48 DYSURIA | 6 0.06 41.54 EAR DISORDER | 2 0.02 41.56 EAR INFECTION | 1 0.01 41.57 EAR MALFORMATION | 1 0.01 41.58 EAR OPERATION COMPLICATION | 1 0.01 41.59 EAR PAIN | 1 0.01 41.60 EAR, NOSE AND THROAT EXAMINATION ABNO.. | 1 0.01 41.61 EATING DISORDER | 6 0.06 41.67 ECCHYMOSIS | 1 0.01 41.68 ECHOCARDIOGRAM ABNORMAL | 1 0.01 41.69 ECONOMIC PROBLEM | 1 0.01 41.70 ECTOPIC PREGNANCY | 1 0.01 41.71 ECZEMA | 1 0.01 41.72 ECZEMA NUMMULAR | 1 0.01 41.73 EFFUSION | 1 0.01 41.74 EJACULATION DISORDER | 1 0.01 41.75 EJACULATION FAILURE | 1 0.01 41.76 EJECTION FRACTION DECREASED | 6 0.06 41.82 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 41.86 ELECTROCARDIOGRAM P WAVE ABNORMAL | 1 0.01 41.87 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 2 0.02 41.89 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED | 1 0.01 41.90 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 4 0.04 41.94 ELECTROCARDIOGRAM QT PROLONGED | 4 0.04 41.98 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 41.99 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 42.00 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 42.01 ELECTROLYTE IMBALANCE | 4 0.04 42.05 ELECTROMECHANICAL DISSOCIATION | 1 0.01 42.06 ELECTROPHORESIS ABNORMAL | 1 0.01 42.07 EMBOLIC CEREBRAL INFARCTION | 2 0.02 42.09 EMBOLIC STROKE | 2 0.02 42.11 EMBOLISM | 3 0.03 42.14 EMOTIONAL DISORDER | 20 0.20 42.34 EMOTIONAL DISTRESS | 11 0.11 42.45 EMPHYSEMA | 7 0.07 42.52 ENANTHEMA | 1 0.01 42.53 ENCEPHALITIS | 2 0.02 42.55 ENCEPHALOMALACIA | 1 0.01 42.56 ENCEPHALOPATHY | 8 0.08 42.64 ENDOCARDITIS | 1 0.01 42.65 ENDOCARDITIS NONINFECTIVE | 1 0.01 42.66 ENDOMETRIAL DISORDER | 2 0.02 42.68 ENDOPHTHALMITIS | 1 0.01 42.69 ENTERITIS | 3 0.03 42.72 ENTEROBACTER BACTERAEMIA | 1 0.01 42.73 ENTEROBACTER PNEUMONIA | 1 0.01 42.74 ENTEROCOCCAL INFECTION | 1 0.01 42.75 ENTEROCOLITIS | 1 0.01 42.76 ENTEROCUTANEOUS FISTULA | 1 0.01 42.77 ENTHESOPATHY | 2 0.02 42.79 EOSINOPHIL COUNT INCREASED | 1 0.01 42.80 EOSINOPHILIA | 3 0.03 42.83 EPICONDYLITIS | 1 0.01 42.84 EPIDERMOLYSIS BULLOSA | 1 0.01 42.85 EPIDIDYMITIS | 1 0.01 42.86 EPIGASTRIC DISCOMFORT | 1 0.01 42.87 EPILEPSY | 5 0.05 42.92 EPISTAXIS | 7 0.07 42.99 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 2 0.02 43.01 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 43.02 ERECTILE DYSFUNCTION | 10 0.10 43.12 EROSIVE DUODENITIS | 1 0.01 43.13 EROSIVE OESOPHAGITIS | 1 0.01 43.14 ERYTHEMA | 22 0.22 43.36 ERYTHRODERMIC PSORIASIS | 1 0.01 43.37 ESCHERICHIA BACTERAEMIA | 1 0.01 43.38 ESCHERICHIA INFECTION | 1 0.01 43.39 ESCHERICHIA SEPSIS | 1 0.01 43.40 ESSENTIAL HYPERTENSION | 3 0.03 43.43 EUSTACHIAN TUBE DISORDER | 1 0.01 43.44 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 43.45 EXCORIATION | 1 0.01 43.46 EXERCISE TOLERANCE DECREASED | 1 0.01 43.47 EXOSTOSIS | 4 0.04 43.51 EXTENSOR PLANTAR RESPONSE | 1 0.01 43.52 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 1 0.01 43.53 EXTRAPYRAMIDAL DISORDER | 4 0.04 43.57 EXTRASYSTOLES | 3 0.03 43.60 EXTRAVASATION | 1 0.01 43.61 EYE ALLERGY | 1 0.01 43.62 EYE DEGENERATIVE DISORDER | 1 0.01 43.63 EYE DISORDER | 4 0.04 43.67 EYE HAEMORRHAGE | 2 0.02 43.69 EYE INFLAMMATION | 1 0.01 43.70 EYE INJURY | 1 0.01 43.71 EYE IRRITATION | 4 0.04 43.75 EYE LASER SURGERY | 1 0.01 43.76 EYE PAIN | 5 0.05 43.81 EYE PENETRATION | 1 0.01 43.82 EYE SWELLING | 1 0.01 43.83 EYELID OEDEMA | 2 0.02 43.85 FACE OEDEMA | 4 0.04 43.89 FACIAL PAIN | 1 0.01 43.90 FACIAL PALSY | 1 0.01 43.91 FACIAL PARESIS | 2 0.02 43.93 FACIAL WASTING | 1 0.01 43.94 FACTOR IX INHIBITION | 1 0.01 43.95 FAECAL INCONTINENCE | 1 0.01 43.96 FAECALOMA | 3 0.03 43.99 FAECES DISCOLOURED | 4 0.04 44.03 FALL | 45 0.45 44.48 FAMILIAL PERIODIC PARALYSIS | 1 0.01 44.49 FANCONI SYNDROME | 1 0.01 44.50 FASCIITIS | 1 0.01 44.51 FATIGUE | 48 0.48 44.99 FEAR | 4 0.04 45.03 FEBRILE NEUTROPENIA | 8 0.08 45.11 FEEDING DISORDER NEONATAL | 1 0.01 45.12 FEELING ABNORMAL | 16 0.16 45.28 FEELING COLD | 4 0.04 45.32 FEELING HOT | 4 0.04 45.36 FEELING JITTERY | 2 0.02 45.38 FEMALE GENITAL TRACT FISTULA | 1 0.01 45.39 FEMORAL NECK FRACTURE | 2 0.02 45.41 FEMUR FRACTURE | 2 0.02 45.43 FIBRIN D DIMER INCREASED | 1 0.01 45.44 FIBROCYSTIC BREAST DISEASE | 1 0.01 45.45 FIBROMA | 1 0.01 45.46 FIBROMYALGIA | 7 0.07 45.53 FINGER AMPUTATION | 1 0.01 45.54 FISTULA | 4 0.04 45.58 FLAIL CHEST | 3 0.03 45.61 FLANK PAIN | 3 0.03 45.64 FLAT AFFECT | 1 0.01 45.65 FLAT FEET | 1 0.01 45.66 FLATULENCE | 2 0.02 45.68 FLUID OVERLOAD | 2 0.02 45.70 FLUID RETENTION | 1 0.01 45.71 FLUSHING | 6 0.06 45.77 FOAMING AT MOUTH | 1 0.01 45.78 FOLLICULITIS | 1 0.01 45.79 FOOD ALLERGY | 1 0.01 45.80 FOOD INTOLERANCE | 1 0.01 45.81 FOOT AMPUTATION | 1 0.01 45.82 FOOT FRACTURE | 3 0.03 45.85 FOOT OPERATION | 1 0.01 45.86 FORCED EXPIRATORY VOLUME DECREASED | 1 0.01 45.87 FOREARM FRACTURE | 1 0.01 45.88 FOREIGN BODY IN EYE | 1 0.01 45.89 FRACTURE | 2 0.02 45.91 FUNGAL INFECTION | 5 0.05 45.96 FUNGAL RASH | 1 0.01 45.97 FUNGAL SKIN INFECTION | 2 0.02 45.99 FUNGUS URINE TEST POSITIVE | 1 0.01 46.00 FURUNCLE | 2 0.02 46.02 GAIT DISTURBANCE | 8 0.08 46.10 GALACTORRHOEA | 1 0.01 46.11 GALLBLADDER DISORDER | 11 0.11 46.22 GALLBLADDER INJURY | 1 0.01 46.23 GALLBLADDER POLYP | 1 0.01 46.24 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 12 0.12 46.36 GASTRIC CANCER | 1 0.01 46.37 GASTRIC DISORDER | 9 0.09 46.46 GASTRIC HAEMORRHAGE | 3 0.03 46.49 GASTRIC INFECTION | 1 0.01 46.50 GASTRIC OPERATION | 1 0.01 46.51 GASTRIC ULCER | 6 0.06 46.57 GASTRIC ULCER HAEMORRHAGE | 2 0.02 46.59 GASTRIC ULCER PERFORATION | 1 0.01 46.60 GASTRITIS | 17 0.17 46.77 GASTRITIS EROSIVE | 2 0.02 46.79 GASTRITIS HAEMORRHAGIC | 1 0.01 46.80 GASTRITIS VIRAL | 1 0.01 46.81 GASTROENTERITIS | 5 0.05 46.86 GASTROENTERITIS SALMONELLA | 1 0.01 46.87 GASTROENTERITIS VIRAL | 2 0.02 46.89 GASTROINTESTINAL DISORDER | 21 0.21 47.10 GASTROINTESTINAL HAEMORRHAGE | 17 0.17 47.27 GASTROINTESTINAL INJURY | 1 0.01 47.28 GASTROINTESTINAL PAIN | 2 0.02 47.30 GASTROINTESTINAL STOMA COMPLICATION | 1 0.01 47.31 GASTROINTESTINAL TRACT ADENOMA | 2 0.02 47.33 GASTROINTESTINAL ULCER HAEMORRHAGE | 1 0.01 47.34 GASTROOESOPHAGEAL REFLUX DISEASE | 42 0.42 47.76 GENERAL ANAESTHESIA | 1 0.01 47.77 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 47.78 GENERAL PHYSICAL HEALTH DETERIORATION | 8 0.08 47.86 GENERAL SYMPTOM | 2 0.02 47.88 GENERALISED ERYTHEMA | 1 0.01 47.89 GENERALISED OEDEMA | 2 0.02 47.91 GENITAL DISORDER MALE | 1 0.01 47.92 GESTATIONAL DIABETES | 1 0.01 47.93 GINGIVAL ATROPHY | 1 0.01 47.94 GINGIVAL BLEEDING | 2 0.02 47.96 GINGIVAL DISORDER | 2 0.02 47.98 GINGIVAL EROSION | 1 0.01 47.99 GINGIVAL HYPERPLASIA | 1 0.01 48.00 GINGIVAL INFECTION | 2 0.02 48.02 GLAUCOMA | 7 0.07 48.09 GLIOMA | 1 0.01 48.10 GLOMERULONEPHRITIS | 1 0.01 48.11 GLOMERULONEPHRITIS PROLIFERATIVE | 2 0.02 48.13 GLOSSITIS | 2 0.02 48.15 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 48.17 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEF.. | 1 0.01 48.18 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 48.20 GOUT | 8 0.08 48.28 GOUTY ARTHRITIS | 2 0.02 48.30 GRAFT COMPLICATION | 1 0.01 48.31 GRAFT VERSUS HOST DISEASE | 1 0.01 48.32 GRAND MAL CONVULSION | 5 0.05 48.37 GRANULOCYTOPENIA | 2 0.02 48.39 GRANULOMA | 3 0.03 48.42 GRANULOMATOUS LIVER DISEASE | 1 0.01 48.43 GRAVITATIONAL OEDEMA | 1 0.01 48.44 GRIP STRENGTH DECREASED | 1 0.01 48.45 GROIN PAIN | 2 0.02 48.47 HAEMARTHROSIS | 1 0.01 48.48 HAEMATEMESIS | 2 0.02 48.50 HAEMATOCHEZIA | 8 0.08 48.58 HAEMATOCRIT DECREASED | 13 0.13 48.71 HAEMATOCRIT INCREASED | 1 0.01 48.72 HAEMATOMA | 5 0.05 48.77 HAEMATOTOXICITY | 1 0.01 48.78 HAEMATURIA | 15 0.15 48.93 HAEMOCHROMATOSIS | 1 0.01 48.94 HAEMODIALYSIS | 9 0.09 49.03 HAEMOGLOBIN DECREASED | 26 0.26 49.29 HAEMOLYTIC ANAEMIA | 1 0.01 49.30 HAEMOPTYSIS | 3 0.03 49.33 HAEMORRHAGE | 19 0.19 49.52 HAEMORRHAGE CORONARY ARTERY | 1 0.01 49.53 HAEMORRHAGE INTRACRANIAL | 4 0.04 49.57 HAEMORRHAGE SUBCUTANEOUS | 2 0.02 49.59 HAEMORRHAGIC CYST | 1 0.01 49.60 HAEMORRHAGIC DIATHESIS | 4 0.04 49.64 HAEMORRHAGIC STROKE | 1 0.01 49.65 HAEMORRHAGIC TRANSFORMATION STROKE | 6 0.06 49.71 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 49.73 HAEMORRHOIDS | 15 0.15 49.88 HAIR GROWTH ABNORMAL | 2 0.02 49.90 HALLUCINATION | 16 0.16 50.06 HALLUCINATION, AUDITORY | 3 0.03 50.09 HALLUCINATION, VISUAL | 2 0.02 50.11 HAND DEFORMITY | 1 0.01 50.12 HAPTOGLOBIN DECREASED | 2 0.02 50.14 HEAD DEFORMITY | 1 0.01 50.15 HEAD DISCOMFORT | 1 0.01 50.16 HEAD INJURY | 3 0.03 50.19 HEADACHE | 66 0.66 50.85 HEARING IMPAIRED | 1 0.01 50.86 HEART DISEASE CONGENITAL | 2 0.02 50.88 HEART INJURY | 7 0.07 50.95 HEART RATE DECREASED | 2 0.02 50.97 HEART RATE INCREASED | 14 0.14 51.11 HEART RATE IRREGULAR | 13 0.13 51.24 HEART VALVE CALCIFICATION | 1 0.01 51.25 HELICOBACTER INFECTION | 1 0.01 51.26 HELICOBACTER PYLORI IDENTIFICATION TE.. | 2 0.02 51.28 HELLP SYNDROME | 1 0.01 51.29 HEMIANOPIA | 1 0.01 51.30 HEMIPARESIS | 13 0.13 51.43 HEMIPLEGIA | 3 0.03 51.46 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 51.47 HEPATIC CIRRHOSIS | 6 0.06 51.53 HEPATIC CYST | 1 0.01 51.54 HEPATIC ENCEPHALOPATHY | 5 0.05 51.59 HEPATIC ENZYME INCREASED | 10 0.10 51.69 HEPATIC FAILURE | 6 0.06 51.75 HEPATIC FIBROSIS | 1 0.01 51.76 HEPATIC FUNCTION ABNORMAL | 7 0.07 51.83 HEPATIC LESION | 1 0.01 51.84 HEPATIC MASS | 1 0.01 51.85 HEPATIC NECROSIS | 2 0.02 51.87 HEPATIC NEOPLASM | 1 0.01 51.88 HEPATIC NEOPLASM MALIGNANT | 4 0.04 51.92 HEPATIC NEOPLASM MALIGNANT RECURRENT | 1 0.01 51.93 HEPATIC STEATOSIS | 11 0.11 52.04 HEPATIC TRAUMA | 1 0.01 52.05 HEPATITIS | 19 0.19 52.24 HEPATITIS ACUTE | 3 0.03 52.27 HEPATITIS B | 2 0.02 52.29 HEPATITIS C | 6 0.06 52.35 HEPATITIS CHOLESTATIC | 2 0.02 52.37 HEPATITIS FULMINANT | 3 0.03 52.40 HEPATITIS TOXIC | 1 0.01 52.41 HEPATOCELLULAR DAMAGE | 16 0.16 52.57 HEPATOMEGALY | 6 0.06 52.63 HEPATOSPLENOMEGALY | 1 0.01 52.64 HEPATOTOXICITY | 1 0.01 52.65 HERNIA | 6 0.06 52.71 HERNIA REPAIR | 2 0.02 52.73 HERPES SIMPLEX | 1 0.01 52.74 HERPES VIRUS INFECTION | 1 0.01 52.75 HERPES ZOSTER | 9 0.09 52.84 HIATUS HERNIA | 5 0.05 52.89 HIDRADENITIS | 2 0.02 52.91 HIGH DENSITY LIPOPROTEIN DECREASED | 3 0.03 52.94 HIP ARTHROPLASTY | 6 0.06 53.00 HIP FRACTURE | 1 0.01 53.01 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 53.03 HOMICIDAL IDEATION | 1 0.01 53.04 HORMONE LEVEL ABNORMAL | 2 0.02 53.06 HOSPITALISATION | 3 0.03 53.09 HOT FLUSH | 4 0.04 53.13 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 1 0.01 53.14 HUMERUS FRACTURE | 1 0.01 53.15 HYDROCEPHALUS | 2 0.02 53.17 HYDRONEPHROSIS | 3 0.03 53.20 HYPERACUSIS | 1 0.01 53.21 HYPERAESTHESIA | 2 0.02 53.23 HYPERAMMONAEMIA | 1 0.01 53.24 HYPERBARIC OXYGEN THERAPY | 1 0.01 53.25 HYPERBILIRUBINAEMIA | 1 0.01 53.26 HYPERCALCAEMIA | 5 0.05 53.31 HYPERCAPNIA | 1 0.01 53.32 HYPERCHOLESTEROLAEMIA | 18 0.18 53.50 HYPERCOAGULATION | 2 0.02 53.52 HYPERGLYCAEMIA | 7 0.07 53.59 HYPERHIDROSIS | 25 0.25 53.84 HYPERHOMOCYSTEINAEMIA | 1 0.01 53.85 HYPERKALAEMIA | 13 0.13 53.98 HYPERKINESIA | 1 0.01 53.99 HYPERLIPIDAEMIA | 34 0.34 54.33 HYPERMETABOLISM | 1 0.01 54.34 HYPERNATRAEMIA | 1 0.01 54.35 HYPEROSMOLAR STATE | 1 0.01 54.36 HYPERPARATHYROIDISM | 1 0.01 54.37 HYPERPARATHYROIDISM PRIMARY | 1 0.01 54.38 HYPERPROLACTINAEMIA | 1 0.01 54.39 HYPERREFLEXIA | 4 0.04 54.43 HYPERSENSITIVITY | 20 0.20 54.63 HYPERSOMNIA | 1 0.01 54.64 HYPERTENSION | 119 1.19 55.83 HYPERTENSIVE CRISIS | 2 0.02 55.85 HYPERTENSIVE HEART DISEASE | 6 0.06 55.91 HYPERTENSIVE NEPHROPATHY | 1 0.01 55.92 HYPERTHERMIA | 1 0.01 55.93 HYPERTHYROIDISM | 2 0.02 55.95 HYPERTONIA | 1 0.01 55.96 HYPERTRICHOSIS | 1 0.01 55.97 HYPERTRIGLYCERIDAEMIA | 5 0.05 56.02 HYPERURICAEMIA | 1 0.01 56.03 HYPERVENTILATION | 2 0.02 56.05 HYPOACUSIS | 2 0.02 56.07 HYPOAESTHESIA | 25 0.25 56.32 HYPOAESTHESIA ORAL | 1 0.01 56.33 HYPOCALCAEMIA | 1 0.01 56.34 HYPOCHROMIC ANAEMIA | 2 0.02 56.36 HYPOGAMMAGLOBULINAEMIA | 1 0.01 56.37 HYPOGLYCAEMIA | 11 0.11 56.48 HYPOGLYCAEMIA UNAWARENESS | 1 0.01 56.49 HYPOGLYCAEMIC COMA | 1 0.01 56.50 HYPOGLYCAEMIC ENCEPHALOPATHY | 1 0.01 56.51 HYPOGONADISM | 1 0.01 56.52 HYPOKALAEMIA | 16 0.16 56.68 HYPOKINESIA | 4 0.04 56.72 HYPOMAGNESAEMIA | 2 0.02 56.74 HYPOMANIA | 1 0.01 56.75 HYPONATRAEMIA | 9 0.09 56.84 HYPOPERFUSION | 1 0.01 56.85 HYPOPHOSPHATAEMIA | 1 0.01 56.86 HYPOREFLEXIA | 1 0.01 56.87 HYPOSMIA | 1 0.01 56.88 HYPOTENSION | 32 0.32 57.20 HYPOTHERMIA | 4 0.04 57.24 HYPOTHYROIDISM | 13 0.13 57.37 HYPOTONIA | 2 0.02 57.39 HYPOVOLAEMIA | 2 0.02 57.41 HYPOXIA | 8 0.08 57.49 HYSTERECTOMY | 2 0.02 57.51 IATROGENIC INJURY | 3 0.03 57.54 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 57.55 ILEAL ULCER PERFORATION | 1 0.01 57.56 ILEOSTOMY | 1 0.01 57.57 ILEUS | 2 0.02 57.59 ILL-DEFINED DISORDER | 3 0.03 57.62 ILLUSION | 1 0.01 57.63 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 57.64 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 57.65 IMPAIRED DRIVING ABILITY | 3 0.03 57.68 IMPAIRED GASTRIC EMPTYING | 2 0.02 57.70 IMPAIRED HEALING | 6 0.06 57.76 IMPAIRED WORK ABILITY | 3 0.03 57.79 IMPINGEMENT SYNDROME | 1 0.01 57.80 IMPULSIVE BEHAVIOUR | 1 0.01 57.81 INADEQUATE ANALGESIA | 2 0.02 57.83 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 2 0.02 57.85 INCISION SITE COMPLICATION | 2 0.02 57.87 INCISIONAL DRAINAGE | 1 0.01 57.88 INCOHERENT | 1 0.01 57.89 INCONTINENCE | 2 0.02 57.91 INCORRECT DOSE ADMINISTERED | 4 0.04 57.95 INCORRECT ROUTE OF DRUG ADMINISTRATION | 3 0.03 57.98 INCREASED APPETITE | 2 0.02 58.00 INCREASED BRONCHIAL SECRETION | 1 0.01 58.01 INCREASED UPPER AIRWAY SECRETION | 1 0.01 58.02 INDIFFERENCE | 1 0.01 58.03 INDURATION | 1 0.01 58.04 INFANT | 1 0.01 58.05 INFARCTION | 4 0.04 58.09 INFECTED INSECT BITE | 1 0.01 58.10 INFECTION | 12 0.12 58.22 INFECTIOUS MONONUCLEOSIS | 1 0.01 58.23 INFECTIVE EXACERBATION OF CHRONIC OBS.. | 2 0.02 58.25 INFECTIVE TENOSYNOVITIS | 1 0.01 58.26 INFECTIVE THROMBOSIS | 1 0.01 58.27 INFLAMMATION | 4 0.04 58.31 INFLAMMATORY BOWEL DISEASE | 5 0.05 58.36 INFLUENZA | 8 0.08 58.44 INFLUENZA LIKE ILLNESS | 7 0.07 58.51 INFUSION RELATED REACTION | 9 0.09 58.60 INFUSION SITE PAIN | 1 0.01 58.61 INGUINAL HERNIA | 3 0.03 58.64 INJECTION SITE ABSCESS | 1 0.01 58.65 INJECTION SITE CELLULITIS | 1 0.01 58.66 INJECTION SITE ERYTHEMA | 3 0.03 58.69 INJECTION SITE INFECTION | 1 0.01 58.70 INJECTION SITE INFLAMMATION | 1 0.01 58.71 INJECTION SITE IRRITATION | 1 0.01 58.72 INJECTION SITE NECROSIS | 1 0.01 58.73 INJECTION SITE PAIN | 4 0.04 58.77 INJECTION SITE PRURITUS | 1 0.01 58.78 INJECTION SITE RASH | 2 0.02 58.80 INJECTION SITE REACTION | 2 0.02 58.82 INJECTION SITE SWELLING | 1 0.01 58.83 INJECTION SITE THROMBOSIS | 1 0.01 58.84 INJECTION SITE URTICARIA | 2 0.02 58.86 INJURY | 27 0.27 59.13 INNER EAR DISORDER | 1 0.01 59.14 INSOMNIA | 33 0.33 59.47 INTENTIONAL DRUG MISUSE | 2 0.02 59.49 INTENTIONAL OVERDOSE | 7 0.07 59.56 INTENTIONAL SELF-INJURY | 1 0.01 59.57 INTERCEPTED MEDICATION ERROR | 2 0.02 59.59 INTERMITTENT CLAUDICATION | 5 0.05 59.64 INTERNAL INJURY | 1 0.01 59.65 INTERNATIONAL NORMALISED RATIO DECREA.. | 2 0.02 59.67 INTERNATIONAL NORMALISED RATIO INCREA.. | 6 0.06 59.73 INTERSTITIAL LUNG DISEASE | 11 0.11 59.84 INTERVERTEBRAL DISC DEGENERATION | 9 0.09 59.93 INTERVERTEBRAL DISC DISORDER | 3 0.03 59.96 INTERVERTEBRAL DISC DISPLACEMENT | 1 0.01 59.97 INTERVERTEBRAL DISC OPERATION | 1 0.01 59.98 INTERVERTEBRAL DISC PROTRUSION | 10 0.10 60.08 INTERVERTEBRAL DISCITIS | 1 0.01 60.09 INTESTINAL FUNCTIONAL DISORDER | 6 0.06 60.15 INTESTINAL HAEMORRHAGE | 6 0.06 60.21 INTESTINAL ISCHAEMIA | 2 0.02 60.23 INTESTINAL OBSTRUCTION | 3 0.03 60.26 INTESTINAL PERFORATION | 1 0.01 60.27 INTESTINAL POLYP | 1 0.01 60.28 INTRACARDIAC THROMBUS | 5 0.05 60.33 INTRACRANIAL ANEURYSM | 2 0.02 60.35 INTRACRANIAL HAEMATOMA | 1 0.01 60.36 INTRACRANIAL PRESSURE INCREASED | 2 0.02 60.38 INTRACRANIAL VENOUS SINUS THROMBOSIS | 1 0.01 60.39 INTRAOCULAR PRESSURE INCREASED | 1 0.01 60.40 INTUBATION | 1 0.01 60.41 IRIDOCYCLITIS | 3 0.03 60.44 IRON BINDING CAPACITY UNSATURATED INC.. | 1 0.01 60.45 IRON DEFICIENCY | 1 0.01 60.46 IRON DEFICIENCY ANAEMIA | 5 0.05 60.51 IRRITABILITY | 5 0.05 60.56 IRRITABLE BOWEL SYNDROME | 1 0.01 60.57 ISCHAEMIA | 3 0.03 60.60 ISCHAEMIC CARDIOMYOPATHY | 4 0.04 60.64 ISCHAEMIC CEREBRAL INFARCTION | 2 0.02 60.66 ISCHAEMIC STROKE | 14 0.14 60.80 JAUNDICE | 10 0.10 60.90 JAUNDICE CHOLESTATIC | 1 0.01 60.91 JAW CYST | 1 0.01 60.92 JAW OPERATION | 3 0.03 60.95 JC VIRUS INFECTION | 1 0.01 60.96 JOINT CONTRACTURE | 1 0.01 60.97 JOINT CREPITATION | 1 0.01 60.98 JOINT DESTRUCTION | 1 0.01 60.99 JOINT DISLOCATION | 1 0.01 61.00 JOINT EFFUSION | 1 0.01 61.01 JOINT INJURY | 13 0.13 61.14 JOINT SPRAIN | 9 0.09 61.23 JOINT SWELLING | 9 0.09 61.32 KERATOCONJUNCTIVITIS SICCA | 1 0.01 61.33 KETOACIDOSIS | 1 0.01 61.34 KIDNEY ENLARGEMENT | 1 0.01 61.35 KIDNEY INFECTION | 2 0.02 61.37 KIDNEY MALFORMATION | 1 0.01 61.38 KIDNEY TRANSPLANT REJECTION | 1 0.01 61.39 KNEE OPERATION | 4 0.04 61.43 LABILE HYPERTENSION | 1 0.01 61.44 LABORATORY TEST INTERFERENCE | 1 0.01 61.45 LABOUR INDUCTION | 1 0.01 61.46 LABYRINTHITIS | 2 0.02 61.48 LACERATION | 3 0.03 61.51 LACTIC ACIDOSIS | 5 0.05 61.56 LACUNAR INFARCTION | 6 0.06 61.62 LARGE INTESTINAL ULCER | 2 0.02 61.64 LARGE INTESTINE PERFORATION | 1 0.01 61.65 LARYNGEAL DISCOMFORT | 1 0.01 61.66 LARYNGEAL DYSPNOEA | 1 0.01 61.67 LARYNGITIS | 1 0.01 61.68 LARYNGOSPASM | 1 0.01 61.69 LARYNGOTRACHEO BRONCHITIS | 1 0.01 61.70 LEFT VENTRICULAR FAILURE | 1 0.01 61.71 LEG AMPUTATION | 2 0.02 61.73 LETHARGY | 8 0.08 61.81 LEUKOARAIOSIS | 1 0.01 61.82 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 61.83 LEUKOCYTOSIS | 6 0.06 61.89 LEUKOENCEPHALOPATHY | 1 0.01 61.90 LEUKOPENIA | 17 0.17 62.07 LIGAMENT INJURY | 3 0.03 62.10 LIMB DISCOMFORT | 5 0.05 62.15 LIMB HYPOPLASIA CONGENITAL | 1 0.01 62.16 LIMB INJURY | 8 0.08 62.24 LIMB MALFORMATION | 2 0.02 62.26 LIMB OPERATION | 1 0.01 62.27 LIP AND/OR ORAL CAVITY CANCER | 2 0.02 62.29 LIP BLISTER | 1 0.01 62.30 LIP DRY | 1 0.01 62.31 LIP EXFOLIATION | 1 0.01 62.32 LIP PAIN | 1 0.01 62.33 LIP ULCERATION | 1 0.01 62.34 LIPASE INCREASED | 3 0.03 62.37 LIPIDS ABNORMAL | 1 0.01 62.38 LIPIDS INCREASED | 1 0.01 62.39 LIPOMA | 3 0.03 62.42 LISTLESS | 1 0.01 62.43 LIVER DISORDER | 13 0.13 62.56 LIVER FUNCTION TEST ABNORMAL | 11 0.11 62.67 LIVER TRANSPLANT | 1 0.01 62.68 LIVER TRANSPLANT REJECTION | 1 0.01 62.69 LOBAR PNEUMONIA | 3 0.03 62.72 LOCAL REACTION | 1 0.01 62.73 LOCAL SWELLING | 2 0.02 62.75 LOCALISED INFECTION | 2 0.02 62.77 LOSS OF CONSCIOUSNESS | 21 0.21 62.98 LOW CARDIAC OUTPUT SYNDROME | 1 0.01 62.99 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 63.01 LOWER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 63.03 LOWER LIMB FRACTURE | 1 0.01 63.04 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 63.07 LUMBAR RADICULOPATHY | 1 0.01 63.08 LUMBAR SPINAL STENOSIS | 3 0.03 63.11 LUNG ADENOCARCINOMA | 1 0.01 63.12 LUNG DISORDER | 5 0.05 63.17 LUNG INFECTION | 2 0.02 63.19 LUNG INFECTION PSEUDOMONAL | 1 0.01 63.20 LUNG INFILTRATION | 7 0.07 63.27 LUNG INJURY | 1 0.01 63.28 LUNG NEOPLASM | 3 0.03 63.31 LUNG NEOPLASM MALIGNANT | 2 0.02 63.33 LYMPHADENOPATHY | 9 0.09 63.42 LYMPHOCYTE COUNT DECREASED | 2 0.02 63.44 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 63.45 LYMPHOCYTE PERCENTAGE INCREASED | 1 0.01 63.46 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 63.47 LYMPHOCYTOSIS | 1 0.01 63.48 LYMPHOMA | 3 0.03 63.51 LYMPHOPENIA | 1 0.01 63.52 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 63.53 MACROCYTOSIS | 2 0.02 63.55 MACULAR DEGENERATION | 3 0.03 63.58 MACULAR OEDEMA | 1 0.01 63.59 MACULOPATHY | 2 0.02 63.61 MAJOR DEPRESSION | 4 0.04 63.65 MALABSORPTION | 1 0.01 63.66 MALAISE | 27 0.27 63.93 MALIGNANT ASCITES | 1 0.01 63.94 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 63.95 MALIGNANT NEOPLASM PROGRESSION | 15 0.15 64.10 MANIA | 1 0.01 64.11 MASKED FACIES | 1 0.01 64.12 MASS | 1 0.01 64.13 MASTECTOMY | 1 0.01 64.14 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 64.15 MEAN CELL HAEMOGLOBIN DECREASED | 1 0.01 64.16 MEAN CELL VOLUME DECREASED | 2 0.02 64.18 MEDICATION ERROR | 10 0.10 64.28 MEDICATION RESIDUE | 1 0.01 64.29 MEGACOLON | 1 0.01 64.30 MELAENA | 9 0.09 64.39 MELANOCYTIC NAEVUS | 1 0.01 64.40 MEMORY IMPAIRMENT | 12 0.12 64.52 MENINGIOMA | 2 0.02 64.54 MENINGITIS | 1 0.01 64.55 MENINGITIS BACTERIAL | 1 0.01 64.56 MENISCUS LESION | 6 0.06 64.62 MENORRHAGIA | 1 0.01 64.63 MENTAL DISORDER | 13 0.13 64.76 MENTAL IMPAIRMENT | 2 0.02 64.78 MENTAL STATUS CHANGES | 12 0.12 64.90 MESENTERIC VASCULAR INSUFFICIENCY | 1 0.01 64.91 METABOLIC ACIDOSIS | 10 0.10 65.01 METABOLIC ENCEPHALOPATHY | 1 0.01 65.02 METABOLIC SYNDROME | 1 0.01 65.03 METASTASES TO BONE | 2 0.02 65.05 METASTASES TO BONE MARROW | 1 0.01 65.06 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 65.07 METASTASES TO LIVER | 1 0.01 65.08 METASTASES TO LUNG | 1 0.01 65.09 METASTASES TO LYMPH NODES | 1 0.01 65.10 METASTASIS | 1 0.01 65.11 METASTATIC MALIGNANT MELANOMA | 1 0.01 65.12 METASTATIC NEOPLASM | 1 0.01 65.13 METATARSAL EXCISION | 1 0.01 65.14 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 1 0.01 65.15 METRORRHAGIA | 1 0.01 65.16 MICROANGIOPATHY | 1 0.01 65.17 MICROCYTIC ANAEMIA | 1 0.01 65.18 MICROTIA | 1 0.01 65.19 MICTURITION DISORDER | 1 0.01 65.20 MICTURITION URGENCY | 1 0.01 65.21 MIDDLE EAR EFFUSION | 1 0.01 65.22 MIDDLE INSOMNIA | 1 0.01 65.23 MIGRAINE | 10 0.10 65.33 MIGRAINE WITHOUT AURA | 1 0.01 65.34 MIOSIS | 1 0.01 65.35 MITRAL VALVE CALCIFICATION | 1 0.01 65.36 MITRAL VALVE DISEASE | 2 0.02 65.38 MITRAL VALVE INCOMPETENCE | 21 0.21 65.59 MITRAL VALVE PROLAPSE | 5 0.05 65.64 MITRAL VALVE REPLACEMENT | 1 0.01 65.65 MITRAL VALVE SCLEROSIS | 1 0.01 65.66 MOLLUSCUM CONTAGIOSUM | 1 0.01 65.67 MONARTHRITIS | 1 0.01 65.68 MONOCYTE COUNT INCREASED | 1 0.01 65.69 MONOCYTE PERCENTAGE DECREASED | 1 0.01 65.70 MONOCYTE PERCENTAGE INCREASED | 2 0.02 65.72 MONONEURITIS | 1 0.01 65.73 MOOD ALTERED | 3 0.03 65.76 MOOD SWINGS | 3 0.03 65.79 MOTION SICKNESS | 1 0.01 65.80 MOUTH HAEMORRHAGE | 4 0.04 65.84 MOUTH INJURY | 2 0.02 65.86 MOUTH ULCERATION | 3 0.03 65.89 MOVEMENT DISORDER | 5 0.05 65.94 MUCOSAL INFLAMMATION | 7 0.07 66.01 MULTI-ORGAN DISORDER | 4 0.04 66.05 MULTI-ORGAN FAILURE | 9 0.09 66.14 MULTIPLE DRUG OVERDOSE INTENTIONAL | 1 0.01 66.15 MULTIPLE FRACTURES | 1 0.01 66.16 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 66.17 MUSCLE ATROPHY | 1 0.01 66.18 MUSCLE CONTRACTURE | 1 0.01 66.19 MUSCLE DISORDER | 1 0.01 66.20 MUSCLE INJURY | 1 0.01 66.21 MUSCLE NECROSIS | 1 0.01 66.22 MUSCLE RIGIDITY | 2 0.02 66.24 MUSCLE SPASMS | 29 0.29 66.53 MUSCLE STRAIN | 5 0.05 66.58 MUSCLE TIGHTNESS | 2 0.02 66.60 MUSCLE TWITCHING | 1 0.01 66.61 MUSCULAR WEAKNESS | 2 0.02 66.63 MUSCULOSKELETAL CHEST PAIN | 15 0.15 66.78 MUSCULOSKELETAL DISCOMFORT | 5 0.05 66.83 MUSCULOSKELETAL DISORDER | 4 0.04 66.87 MUSCULOSKELETAL PAIN | 1 0.01 66.88 MUSCULOSKELETAL STIFFNESS | 5 0.05 66.93 MYALGIA | 22 0.22 67.15 MYDRIASIS | 2 0.02 67.17 MYELODYSPLASTIC SYNDROME | 2 0.02 67.19 MYELOPROLIFERATIVE DISORDER | 1 0.01 67.20 MYOCARDIAL HAEMORRHAGE | 1 0.01 67.21 MYOCARDIAL INFARCTION | 307 3.07 70.28 MYOCARDIAL ISCHAEMIA | 18 0.18 70.46 MYOCARDIAL RUPTURE | 1 0.01 70.47 MYOCARDITIS | 1 0.01 70.48 MYOCLONUS | 2 0.02 70.50 MYOFASCIAL PAIN SYNDROME | 2 0.02 70.52 MYOPATHY | 1 0.01 70.53 MYOSITIS | 2 0.02 70.55 NAIL DISORDER | 2 0.02 70.57 NAIL INFECTION | 1 0.01 70.58 NARCOLEPSY | 1 0.01 70.59 NARCOTIC INTOXICATION | 1 0.01 70.60 NASAL CONGESTION | 3 0.03 70.63 NASAL DISCOMFORT | 1 0.01 70.64 NASAL DISORDER | 1 0.01 70.65 NASAL DRYNESS | 2 0.02 70.67 NASAL SEPTUM DEVIATION | 1 0.01 70.68 NASOPHARYNGITIS | 9 0.09 70.77 NAUSEA | 64 0.64 71.41 NECK INJURY | 5 0.05 71.46 NECK PAIN | 14 0.14 71.60 NECROSIS | 2 0.02 71.62 NEONATAL DISORDER | 1 0.01 71.63 NEOPLASM | 2 0.02 71.65 NEOPLASM MALIGNANT | 2 0.02 71.67 NEPHROLITHIASIS | 11 0.11 71.78 NEPHROPATHY | 1 0.01 71.79 NEPHROPATHY TOXIC | 2 0.02 71.81 NEPHROSCLEROSIS | 3 0.03 71.84 NEPHROTIC SYNDROME | 2 0.02 71.86 NERVE COMPRESSION | 4 0.04 71.90 NERVE INJURY | 2 0.02 71.92 NERVOUS SYSTEM DISORDER | 6 0.06 71.98 NERVOUSNESS | 8 0.08 72.06 NEURALGIA | 2 0.02 72.08 NEURALGIC AMYOTROPHY | 1 0.01 72.09 NEURODERMATITIS | 1 0.01 72.10 NEUROGENIC BLADDER | 1 0.01 72.11 NEUROLEPTIC MALIGNANT SYNDROME | 2 0.02 72.13 NEUROLOGICAL SYMPTOM | 2 0.02 72.15 NEUROMYELITIS OPTICA | 1 0.01 72.16 NEUROPATHY | 1 0.01 72.17 NEUROPATHY PERIPHERAL | 6 0.06 72.23 NEUTROPENIA | 9 0.09 72.32 NEUTROPENIC SEPSIS | 1 0.01 72.33 NEUTROPHIL COUNT ABNORMAL | 1 0.01 72.34 NEUTROPHIL COUNT DECREASED | 3 0.03 72.37 NEUTROPHIL COUNT INCREASED | 1 0.01 72.38 NEUTROPHIL PERCENTAGE DECREASED | 2 0.02 72.40 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 72.41 NICOTINE DEPENDENCE | 2 0.02 72.43 NIGHT BLINDNESS | 1 0.01 72.44 NIGHT SWEATS | 5 0.05 72.49 NIGHTMARE | 1 0.01 72.50 NO ADVERSE EFFECT | 8 0.08 72.58 NO THERAPEUTIC RESPONSE | 2 0.02 72.60 NOCARDIOSIS | 1 0.01 72.61 NOCTURIA | 3 0.03 72.64 NODAL ARRHYTHMIA | 1 0.01 72.65 NODAL RHYTHM | 2 0.02 72.67 NODULE | 1 0.01 72.68 NON-CARDIAC CHEST PAIN | 1 0.01 72.69 NON-HODGKIN'S LYMPHOMA | 3 0.03 72.72 NORMAL DELIVERY | 2 0.02 72.74 NORMAL NEWBORN | 1 0.01 72.75 NORMOCHROMIC NORMOCYTIC ANAEMIA | 6 0.06 72.81 NOSOCOMIAL INFECTION | 1 0.01 72.82 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 72.83 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 72.84 NUTRITIONAL SUPPORT | 2 0.02 72.86 OBESITY | 13 0.13 72.99 OBSESSIVE THOUGHTS | 1 0.01 73.00 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 73.01 OBSTRUCTION | 2 0.02 73.03 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 73.05 OCCULT BLOOD POSITIVE | 1 0.01 73.06 OCULAR HYPERAEMIA | 6 0.06 73.12 OCULAR VASCULAR DISORDER | 2 0.02 73.14 OCULOAURICULOVERTEBRAL DYSPLASIA | 2 0.02 73.16 ODYNOPHAGIA | 4 0.04 73.20 OEDEMA | 26 0.26 73.46 OEDEMA MOUTH | 1 0.01 73.47 OEDEMA PERIPHERAL | 53 0.53 74.00 OESOPHAGEAL ADENOCARCINOMA METASTATIC | 1 0.01 74.01 OESOPHAGEAL ATRESIA | 1 0.01 74.02 OESOPHAGEAL CANDIDIASIS | 2 0.02 74.04 OESOPHAGEAL DISORDER | 1 0.01 74.05 OESOPHAGEAL OEDEMA | 1 0.01 74.06 OESOPHAGEAL PAIN | 1 0.01 74.07 OESOPHAGEAL RUPTURE | 1 0.01 74.08 OESOPHAGEAL SPASM | 1 0.01 74.09 OESOPHAGEAL STENOSIS | 1 0.01 74.10 OESOPHAGEAL ULCER | 1 0.01 74.11 OESOPHAGITIS | 9 0.09 74.20 OESTROGEN DEFICIENCY | 1 0.01 74.21 OFF LABEL USE | 1 0.01 74.22 OLIGURIA | 2 0.02 74.24 OMENTECTOMY | 1 0.01 74.25 ONCOCYTOMA | 1 0.01 74.26 ONYCHOMYCOSIS | 3 0.03 74.29 OPEN FRACTURE | 1 0.01 74.30 OPEN WOUND | 3 0.03 74.33 OPERATIVE HAEMORRHAGE | 1 0.01 74.34 OPTIC NEURITIS | 1 0.01 74.35 OPTIC NEUROPATHY | 1 0.01 74.36 ORAL CANDIDIASIS | 1 0.01 74.37 ORAL INFECTION | 1 0.01 74.38 ORAL INTAKE REDUCED | 5 0.05 74.43 ORAL LICHEN PLANUS | 1 0.01 74.44 ORAL MUCOSA EROSION | 1 0.01 74.45 ORAL MUCOSAL BLISTERING | 1 0.01 74.46 ORAL MUCOSAL PETECHIAE | 1 0.01 74.47 ORAL PAIN | 4 0.04 74.51 ORAL SOFT TISSUE DISORDER | 5 0.05 74.56 ORAL SURGERY | 1 0.01 74.57 ORCHITIS | 1 0.01 74.58 ORGAN FAILURE | 7 0.07 74.65 ORTHOSTATIC HYPOTENSION | 5 0.05 74.70 OSTEITIS | 3 0.03 74.73 OSTEOARTHRITIS | 27 0.27 75.00 OSTEOCHONDROSIS | 2 0.02 75.02 OSTEOGENESIS IMPERFECTA | 1 0.01 75.03 OSTEOLYSIS | 3 0.03 75.06 OSTEOMYELITIS | 6 0.06 75.12 OSTEOMYELITIS CHRONIC | 1 0.01 75.13 OSTEONECROSIS | 33 0.33 75.46 OSTEOPENIA | 1 0.01 75.47 OSTEOPOROSIS | 12 0.12 75.59 OTITIS EXTERNA | 3 0.03 75.62 OVARIAN CANCER | 1 0.01 75.63 OVARIAN CYST | 6 0.06 75.69 OVERDOSE | 32 0.32 76.01 OXYGEN SATURATION DECREASED | 6 0.06 76.07 PAIN | 54 0.54 76.61 PAIN IN EXTREMITY | 34 0.34 76.95 PAIN IN JAW | 9 0.09 77.04 PAINFUL DEFAECATION | 1 0.01 77.05 PALATAL DISORDER | 1 0.01 77.06 PALLOR | 3 0.03 77.09 PALPITATIONS | 22 0.22 77.31 PANCREATIC ATROPHY | 2 0.02 77.33 PANCREATIC CARCINOMA METASTATIC | 1 0.01 77.34 PANCREATIC DUCT DILATATION | 1 0.01 77.35 PANCREATIC ENLARGEMENT | 1 0.01 77.36 PANCREATIC INSUFFICIENCY | 1 0.01 77.37 PANCREATITIS | 12 0.12 77.49 PANCREATITIS ACUTE | 4 0.04 77.53 PANCREATITIS HAEMORRHAGIC | 1 0.01 77.54 PANCYTOPENIA | 9 0.09 77.63 PANIC ATTACK | 7 0.07 77.70 PANIC DISORDER | 2 0.02 77.72 PANIC REACTION | 2 0.02 77.74 PARAESTHESIA | 19 0.19 77.93 PARALYSIS | 3 0.03 77.96 PARANASAL SINUS HYPERSECRETION | 1 0.01 77.97 PARANOIA | 5 0.05 78.02 PARATHYROID DISORDER | 1 0.01 78.03 PARESIS | 2 0.02 78.05 PARKINSON'S DISEASE | 1 0.01 78.06 PARKINSONISM | 2 0.02 78.08 PAROSMIA | 1 0.01 78.09 PARTIAL SEIZURES | 2 0.02 78.11 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 78.12 PATHOGEN RESISTANCE | 2 0.02 78.14 PATHOLOGICAL FRACTURE | 1 0.01 78.15 PCO2 DECREASED | 1 0.01 78.16 PELVIC FRACTURE | 2 0.02 78.18 PELVIC VENOUS THROMBOSIS | 1 0.01 78.19 PEMPHIGOID | 1 0.01 78.20 PENILE PROSTHESIS INSERTION | 1 0.01 78.21 PENIS DISORDER | 1 0.01 78.22 PEPTIC ULCER | 4 0.04 78.26 PEPTIC ULCER PERFORATION | 1 0.01 78.27 PERFORATED ULCER | 1 0.01 78.28 PERFORMANCE STATUS DECREASED | 1 0.01 78.29 PERIARTHRITIS | 2 0.02 78.31 PERICARDIAL EFFUSION | 5 0.05 78.36 PERICARDITIS | 1 0.01 78.37 PERICARDITIS TUBERCULOUS | 1 0.01 78.38 PERIODONTAL DISEASE | 1 0.01 78.39 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 2 0.02 78.41 PERIPHERAL COLDNESS | 1 0.01 78.42 PERIPHERAL ISCHAEMIA | 1 0.01 78.43 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 78.44 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 78.45 PERIPHERAL VASCULAR DISORDER | 9 0.09 78.54 PERITONEAL DIALYSIS | 1 0.01 78.55 PERITONEAL EFFUSION | 1 0.01 78.56 PERITONEAL TUBERCULOSIS | 3 0.03 78.59 PERITONITIS | 5 0.05 78.64 PERITONITIS BACTERIAL | 1 0.01 78.65 PERSONALITY CHANGE | 2 0.02 78.67 PERSONALITY DISORDER | 1 0.01 78.68 PETECHIAE | 3 0.03 78.71 PHARMACEUTICAL PRODUCT COMPLAINT | 11 0.11 78.82 PHARYNGEAL OEDEMA | 3 0.03 78.85 PHARYNGITIS | 2 0.02 78.87 PHARYNGITIS STREPTOCOCCAL | 1 0.01 78.88 PHARYNGOLARYNGEAL PAIN | 12 0.12 79.00 PHARYNX DISCOMFORT | 1 0.01 79.01 PHOTOSENSITIVITY REACTION | 1 0.01 79.02 PHYSIOTHERAPY | 1 0.01 79.03 PITYRIASIS | 1 0.01 79.04 PLANTAR FASCIITIS | 3 0.03 79.07 PLATELET COUNT DECREASED | 22 0.22 79.29 PLATELET COUNT INCREASED | 3 0.03 79.32 PLEURAL EFFUSION | 23 0.23 79.55 PLEURISY | 1 0.01 79.56 PNEUMATOSIS INTESTINALIS | 2 0.02 79.58 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 79.60 PNEUMONIA | 53 0.53 80.13 PNEUMONIA ASPIRATION | 4 0.04 80.17 PNEUMONIA BACTERIAL | 2 0.02 80.19 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 80.20 PNEUMONIA PNEUMOCOCCAL | 2 0.02 80.22 PNEUMONIA VIRAL | 1 0.01 80.23 PNEUMONITIS | 3 0.03 80.26 PNEUMOTHORAX | 4 0.04 80.30 PO2 DECREASED | 2 0.02 80.32 POISONING | 1 0.01 80.33 POLLAKIURIA | 9 0.09 80.42 POLYARTHRITIS | 5 0.05 80.47 POLYCYTHAEMIA | 1 0.01 80.48 POLYDIPSIA | 3 0.03 80.51 POLYMYALGIA | 1 0.01 80.52 POLYMYOSITIS | 1 0.01 80.53 POLYNEUROPATHY | 2 0.02 80.55 POLYP | 2 0.02 80.57 POLYP COLORECTAL | 1 0.01 80.58 POLYPECTOMY | 2 0.02 80.60 POLYTRAUMATISM | 24 0.24 80.84 POLYURIA | 2 0.02 80.86 POOR PERIPHERAL CIRCULATION | 1 0.01 80.87 POOR QUALITY DRUG ADMINISTERED | 3 0.03 80.90 POOR SUCKING REFLEX | 1 0.01 80.91 POST LAMINECTOMY SYNDROME | 2 0.02 80.93 POST PROCEDURAL COMPLICATION | 5 0.05 80.98 POST PROCEDURAL DIARRHOEA | 1 0.01 80.99 POST PROCEDURAL HAEMORRHAGE | 3 0.03 81.02 POST PROCEDURAL NAUSEA | 1 0.01 81.03 POST PROCEDURAL VOMITING | 1 0.01 81.04 POST-TRAUMATIC STRESS DISORDER | 1 0.01 81.05 POSTERIOR CAPSULE RUPTURE | 1 0.01 81.06 POSTICTAL PARALYSIS | 1 0.01 81.07 POSTMATURE BABY | 1 0.01 81.08 POSTOPERATIVE FEVER | 1 0.01 81.09 POSTOPERATIVE INFECTION | 2 0.02 81.11 POSTOPERATIVE WOUND INFECTION | 1 0.01 81.12 PRE-ECLAMPSIA | 1 0.01 81.13 PRECEREBRAL ARTERY OCCLUSION | 1 0.01 81.14 PREGNANCY | 12 0.12 81.26 PREMATURE BABY | 2 0.02 81.28 PREMATURE LABOUR | 4 0.04 81.32 PRESCRIBED OVERDOSE | 12 0.12 81.44 PRIMARY SEQUESTRUM | 3 0.03 81.47 PRINZMETAL ANGINA | 1 0.01 81.48 PROCEDURAL COMPLICATION | 2 0.02 81.50 PROCEDURAL PAIN | 1 0.01 81.51 PROCEDURAL SITE REACTION | 2 0.02 81.53 PRODUCTIVE COUGH | 4 0.04 81.57 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 81.58 PROPOFOL INFUSION SYNDROME | 2 0.02 81.60 PROSTATE CANCER | 2 0.02 81.62 PROSTATE EXAMINATION ABNORMAL | 3 0.03 81.65 PROSTATIC ADENOMA | 1 0.01 81.66 PROSTATIC DISORDER | 1 0.01 81.67 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 81.68 PROSTATISM | 1 0.01 81.69 PROSTATITIS | 4 0.04 81.73 PROTEIN S DECREASED | 1 0.01 81.74 PROTEIN TOTAL DECREASED | 3 0.03 81.77 PROTEIN TOTAL INCREASED | 1 0.01 81.78 PROTEIN URINE PRESENT | 1 0.01 81.79 PROTEINURIA | 3 0.03 81.82 PROTHROMBIN LEVEL DECREASED | 1 0.01 81.83 PROTHROMBIN LEVEL INCREASED | 1 0.01 81.84 PROTHROMBIN TIME PROLONGED | 2 0.02 81.86 PROTHROMBIN TIME SHORTENED | 2 0.02 81.88 PRURITUS | 20 0.20 82.08 PSEUDOCYST | 1 0.01 82.09 PSEUDODEMENTIA | 1 0.01 82.10 PSEUDOMONAS INFECTION | 4 0.04 82.14 PSORIASIS | 3 0.03 82.17 PSYCHIATRIC SYMPTOM | 2 0.02 82.19 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 82.21 PSYCHOTIC DISORDER | 3 0.03 82.24 PULMONARY CONGESTION | 9 0.09 82.33 PULMONARY EMBOLISM | 53 0.53 82.86 PULMONARY FIBROSIS | 4 0.04 82.90 PULMONARY GRANULOMA | 2 0.02 82.92 PULMONARY HAEMORRHAGE | 1 0.01 82.93 PULMONARY HYPERTENSION | 7 0.07 83.00 PULMONARY INFARCTION | 1 0.01 83.01 PULMONARY MASS | 1 0.01 83.02 PULMONARY OEDEMA | 4 0.04 83.06 PULMONARY THROMBOSIS | 2 0.02 83.08 PULMONARY TOXICITY | 1 0.01 83.09 PULMONARY TUBERCULOSIS | 2 0.02 83.11 PULMONARY VALVE STENOSIS | 1 0.01 83.12 PULSE ABSENT | 3 0.03 83.15 PUPILLARY REFLEX IMPAIRED | 1 0.01 83.16 PUPILS UNEQUAL | 1 0.01 83.17 PURPURA | 4 0.04 83.21 PURULENCE | 1 0.01 83.22 PURULENT DISCHARGE | 3 0.03 83.25 PUSTULAR PSORIASIS | 3 0.03 83.28 PYELONEPHRITIS | 1 0.01 83.29 PYELONEPHRITIS ACUTE | 2 0.02 83.31 PYREXIA | 63 0.63 83.94 PYROMANIA | 1 0.01 83.95 PYURIA | 1 0.01 83.96 QUADRIPARESIS | 1 0.01 83.97 RADIATION MYELOPATHY | 1 0.01 83.98 RADICULAR SYNDROME | 1 0.01 83.99 RADICULOPATHY | 6 0.06 84.05 RADIOTHERAPY | 1 0.01 84.06 RADIUS FRACTURE | 2 0.02 84.08 RALES | 1 0.01 84.09 RASH | 40 0.40 84.49 RASH ERYTHEMATOUS | 4 0.04 84.53 RASH GENERALISED | 7 0.07 84.60 RASH MACULAR | 2 0.02 84.62 RASH MACULO-PAPULAR | 2 0.02 84.64 RASH MORBILLIFORM | 1 0.01 84.65 RASH NEONATAL | 1 0.01 84.66 RASH PAPULAR | 3 0.03 84.69 RASH PRURITIC | 1 0.01 84.70 RASH PUSTULAR | 1 0.01 84.71 RECTAL HAEMORRHAGE | 16 0.16 84.87 RECTAL POLYP | 2 0.02 84.89 RED BLOOD CELL COUNT DECREASED | 12 0.12 85.01 RED BLOOD CELL SCHISTOCYTES PRESENT | 1 0.01 85.02 RED BLOOD CELL SEDIMENTATION RATE INC.. | 5 0.05 85.07 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 85.08 RED MAN SYNDROME | 1 0.01 85.09 REFLUX GASTRITIS | 1 0.01 85.10 REFLUX OESOPHAGITIS | 2 0.02 85.12 REFUSAL OF TREATMENT BY PATIENT | 1 0.01 85.13 REHABILITATION THERAPY | 1 0.01 85.14 RENAL ARTERY ARTERIOSCLEROSIS | 1 0.01 85.15 RENAL ARTERY STENOSIS | 3 0.03 85.18 RENAL ARTERY STENT PLACEMENT | 1 0.01 85.19 RENAL COLIC | 1 0.01 85.20 RENAL CYST | 4 0.04 85.24 RENAL DISORDER | 13 0.13 85.37 RENAL EMBOLISM | 1 0.01 85.38 RENAL FAILURE | 32 0.32 85.70 RENAL FAILURE ACUTE | 37 0.37 86.07 RENAL FAILURE CHRONIC | 9 0.09 86.16 RENAL HAEMATOMA | 1 0.01 86.17 RENAL IMPAIRMENT | 13 0.13 86.30 RENAL INFARCT | 1 0.01 86.31 RENAL INJURY | 5 0.05 86.36 RENAL NECROSIS | 1 0.01 86.37 RENAL PAIN | 1 0.01 86.38 RENAL TRANSPLANT | 1 0.01 86.39 RENAL TUBULAR DISORDER | 1 0.01 86.40 RENAL TUBULAR NECROSIS | 1 0.01 86.41 RENAL VEIN THROMBOSIS | 1 0.01 86.42 RENAL VESSEL DISORDER | 1 0.01 86.43 REPERFUSION ARRHYTHMIA | 1 0.01 86.44 REPERFUSION INJURY | 1 0.01 86.45 RESPIRATORY ACIDOSIS | 3 0.03 86.48 RESPIRATORY ARREST | 10 0.10 86.58 RESPIRATORY DEPRESSION | 1 0.01 86.59 RESPIRATORY DISORDER | 8 0.08 86.67 RESPIRATORY DISTRESS | 10 0.10 86.77 RESPIRATORY FAILURE | 20 0.20 86.97 RESPIRATORY GAS EXCHANGE DISORDER | 1 0.01 86.98 RESPIRATORY RATE INCREASED | 2 0.02 87.00 RESPIRATORY TRACT INFECTION | 3 0.03 87.03 RESTLESS LEGS SYNDROME | 3 0.03 87.06 RESTLESSNESS | 6 0.06 87.12 RETAINED PLACENTA OR MEMBRANES | 1 0.01 87.13 RETCHING | 1 0.01 87.14 RETINAL ARTERY OCCLUSION | 1 0.01 87.15 RETINAL ARTERY SPASM | 1 0.01 87.16 RETINAL DEGENERATION | 1 0.01 87.17 RETINAL HAEMORRHAGE | 1 0.01 87.18 RETINAL TEAR | 1 0.01 87.19 RETINAL VEIN THROMBOSIS | 1 0.01 87.20 RETINOPATHY | 1 0.01 87.21 RETROPERITONEAL HAEMATOMA | 1 0.01 87.22 RETROVIRAL INFECTION | 1 0.01 87.23 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 1 0.01 87.24 RHABDOMYOLYSIS | 9 0.09 87.33 RHEUMATIC FEVER | 1 0.01 87.34 RHEUMATOID ARTHRITIS | 8 0.08 87.42 RHEUMATOID FACTOR POSITIVE | 1 0.01 87.43 RHINITIS ALLERGIC | 5 0.05 87.48 RHINITIS SEASONAL | 1 0.01 87.49 RHONCHI | 1 0.01 87.50 RIB FRACTURE | 6 0.06 87.56 ROAD TRAFFIC ACCIDENT | 20 0.20 87.76 ROSACEA | 1 0.01 87.77 ROTATOR CUFF REPAIR | 1 0.01 87.78 ROTATOR CUFF SYNDROME | 9 0.09 87.87 RUPTURED CEREBRAL ANEURYSM | 1 0.01 87.88 SACROILIITIS | 1 0.01 87.89 SALIVARY HYPERSECRETION | 2 0.02 87.91 SARCOIDOSIS | 2 0.02 87.93 SCHIZOAFFECTIVE DISORDER | 1 0.01 87.94 SCHIZOPHRENIA | 4 0.04 87.98 SCIATICA | 5 0.05 88.03 SCLERAL DISCOLOURATION | 1 0.01 88.04 SCREAMING | 1 0.01 88.05 SCROTAL OEDEMA | 1 0.01 88.06 SEBORRHOEIC DERMATITIS | 1 0.01 88.07 SEBORRHOEIC KERATOSIS | 1 0.01 88.08 SECONDARY IMMUNODEFICIENCY | 1 0.01 88.09 SECRETION DISCHARGE | 1 0.01 88.10 SEDATION | 2 0.02 88.12 SELF INJURIOUS BEHAVIOUR | 1 0.01 88.13 SEMINAL VESICULAR DISORDER | 1 0.01 88.14 SENILE DEMENTIA | 1 0.01 88.15 SENSATION OF FOREIGN BODY | 1 0.01 88.16 SENSATION OF HEAVINESS | 1 0.01 88.17 SENSORY DISTURBANCE | 1 0.01 88.18 SENSORY LOSS | 1 0.01 88.19 SEPSIS | 14 0.14 88.33 SEPSIS SYNDROME | 1 0.01 88.34 SEPTIC SHOCK | 8 0.08 88.42 SEQUESTRECTOMY | 1 0.01 88.43 SEROMA | 1 0.01 88.44 SEROTONIN SYNDROME | 1 0.01 88.45 SERUM FERRITIN INCREASED | 2 0.02 88.47 SEXUAL DYSFUNCTION | 1 0.01 88.48 SHOCK | 11 0.11 88.59 SHOCK HYPOGLYCAEMIC | 1 0.01 88.60 SHOULDER OPERATION | 1 0.01 88.61 SHOULDER PAIN | 16 0.16 88.77 SICK SINUS SYNDROME | 2 0.02 88.79 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 88.80 SILENT MYOCARDIAL INFARCTION | 1 0.01 88.81 SINUS ARREST | 1 0.01 88.82 SINUS BRADYCARDIA | 9 0.09 88.91 SINUS CONGESTION | 1 0.01 88.92 SINUS DISORDER | 4 0.04 88.96 SINUS HEADACHE | 1 0.01 88.97 SINUS TACHYCARDIA | 2 0.02 88.99 SINUSITIS | 9 0.09 89.08 SJOGREN'S SYNDROME | 1 0.01 89.09 SKIN BURNING SENSATION | 1 0.01 89.10 SKIN CANCER | 2 0.02 89.12 SKIN CANDIDA | 2 0.02 89.14 SKIN DISCOLOURATION | 5 0.05 89.19 SKIN DISORDER | 1 0.01 89.20 SKIN EXFOLIATION | 4 0.04 89.24 SKIN GRAFT | 1 0.01 89.25 SKIN HAEMORRHAGE | 1 0.01 89.26 SKIN INFECTION | 1 0.01 89.27 SKIN LACERATION | 7 0.07 89.34 SKIN LESION | 1 0.01 89.35 SKIN NEOPLASM EXCISION | 1 0.01 89.36 SKIN NODULE | 1 0.01 89.37 SKIN STRIAE | 1 0.01 89.38 SKIN SWELLING | 1 0.01 89.39 SKIN ULCER | 8 0.08 89.47 SKULL MALFORMATION | 1 0.01 89.48 SLEEP APNOEA SYNDROME | 19 0.19 89.67 SLEEP DISORDER | 13 0.13 89.80 SLEEP WALKING | 1 0.01 89.81 SMALL INTESTINAL OBSTRUCTION | 3 0.03 89.84 SMALL INTESTINAL RESECTION | 1 0.01 89.85 SOCIAL PHOBIA | 1 0.01 89.86 SOFT TISSUE INFECTION | 1 0.01 89.87 SOFT TISSUE INJURY | 1 0.01 89.88 SOMATOFORM DISORDER | 1 0.01 89.89 SOMNOLENCE | 10 0.10 89.99 SPEECH DISORDER | 6 0.06 90.05 SPEECH REHABILITATION | 1 0.01 90.06 SPIDER NAEVUS | 1 0.01 90.07 SPINAL COLUMN STENOSIS | 7 0.07 90.14 SPINAL COMPRESSION FRACTURE | 1 0.01 90.15 SPINAL CORD INJURY | 1 0.01 90.16 SPINAL DISORDER | 7 0.07 90.23 SPINAL FRACTURE | 1 0.01 90.24 SPINAL OSTEOARTHRITIS | 7 0.07 90.31 SPINE MALFORMATION | 1 0.01 90.32 SPLEEN DISORDER | 1 0.01 90.33 SPLENIC ARTERY ANEURYSM | 1 0.01 90.34 SPLENIC GRANULOMA | 1 0.01 90.35 SPLENIC HAEMORRHAGE | 1 0.01 90.36 SPLENIC INFARCTION | 1 0.01 90.37 SPLENIC INJURY | 1 0.01 90.38 SPLENIC RUPTURE | 1 0.01 90.39 SPLENOMEGALY | 2 0.02 90.41 SPORTS INJURY | 1 0.01 90.42 SPUTUM DISCOLOURED | 1 0.01 90.43 SQUAMOUS CELL CARCINOMA | 2 0.02 90.45 STAPHYLOCOCCAL BACTERAEMIA | 3 0.03 90.48 STAPHYLOCOCCAL INFECTION | 11 0.11 90.59 STAPHYLOCOCCAL SEPSIS | 1 0.01 90.60 STARVATION | 2 0.02 90.62 STASIS DERMATITIS | 1 0.01 90.63 STATUS EPILEPTICUS | 1 0.01 90.64 STENT PLACEMENT | 5 0.05 90.69 STEVENS-JOHNSON SYNDROME | 3 0.03 90.72 STOMACH DISCOMFORT | 10 0.10 90.82 STOMACH SCAN ABNORMAL | 1 0.01 90.83 STOMATITIS | 4 0.04 90.87 STRABISMUS | 1 0.01 90.88 STREPTOCOCCAL INFECTION | 1 0.01 90.89 STRESS | 5 0.05 90.94 STRESS INCONTINENCE | 4 0.04 90.98 STRIDOR | 3 0.03 91.01 STUPOR | 1 0.01 91.02 SUBARACHNOID HAEMORRHAGE | 2 0.02 91.04 SUBCUTANEOUS ABSCESS | 3 0.03 91.07 SUBCUTANEOUS HAEMATOMA | 1 0.01 91.08 SUBDURAL HAEMATOMA | 3 0.03 91.11 SUBILEUS | 1 0.01 91.12 SUDDEN CARDIAC DEATH | 4 0.04 91.16 SUDDEN DEATH | 8 0.08 91.24 SUDDEN HEARING LOSS | 1 0.01 91.25 SUICIDAL IDEATION | 12 0.12 91.37 SUICIDE ATTEMPT | 9 0.09 91.46 SUPERIOR SAGITTAL SINUS THROMBOSIS | 1 0.01 91.47 SUPRAVENTRICULAR EXTRASYSTOLES | 6 0.06 91.53 SUPRAVENTRICULAR TACHYCARDIA | 6 0.06 91.59 SURGERY | 15 0.15 91.74 SWELLING | 13 0.13 91.87 SWELLING FACE | 7 0.07 91.94 SWOLLEN TONGUE | 2 0.02 91.96 SYNCOPE | 20 0.20 92.16 SYNCOPE VASOVAGAL | 2 0.02 92.18 SYNOVIAL CYST | 3 0.03 92.21 SYNOVITIS | 1 0.01 92.22 SYSTEMIC CANDIDA | 2 0.02 92.24 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 92.27 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 92.28 SYSTOLIC HYPERTENSION | 1 0.01 92.29 T-LYMPHOCYTE COUNT DECREASED | 1 0.01 92.30 TACHYCARDIA | 17 0.17 92.47 TACHYPNOEA | 5 0.05 92.52 TARDIVE DYSKINESIA | 1 0.01 92.53 TEARFULNESS | 1 0.01 92.54 TEMPERATURE INTOLERANCE | 2 0.02 92.56 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 92.57 TENDERNESS | 2 0.02 92.59 TENDON DISORDER | 2 0.02 92.61 TENDON INJURY | 1 0.01 92.62 TENDON RUPTURE | 2 0.02 92.64 TENDONITIS | 3 0.03 92.67 TENSION | 1 0.01 92.68 TESTICULAR NEOPLASM | 1 0.01 92.69 THERAPEUTIC AGENT TOXICITY | 2 0.02 92.71 THERAPEUTIC PRODUCT INEFFECTIVE | 2 0.02 92.73 THERAPEUTIC RESPONSE DECREASED | 2 0.02 92.75 THERAPEUTIC RESPONSE UNEXPECTED | 1 0.01 92.76 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 1 0.01 92.77 THERAPY NON-RESPONDER | 4 0.04 92.81 THERMAL BURN | 2 0.02 92.83 THINKING ABNORMAL | 2 0.02 92.85 THROAT CANCER | 2 0.02 92.87 THROAT IRRITATION | 1 0.01 92.88 THROAT TIGHTNESS | 3 0.03 92.91 THROMBOCYTHAEMIA | 3 0.03 92.94 THROMBOCYTOPENIA | 15 0.15 93.09 THROMBOCYTOPENIC PURPURA | 1 0.01 93.10 THROMBOPHLEBITIS | 1 0.01 93.11 THROMBOSIS | 60 0.60 93.71 THROMBOTIC STROKE | 4 0.04 93.75 THROMBOTIC THROMBOCYTOPENIC PURPURA | 4 0.04 93.79 THYROID DISORDER | 8 0.08 93.87 THYROID NEOPLASM | 1 0.01 93.88 THYROIDECTOMY | 1 0.01 93.89 THYROXINE INCREASED | 1 0.01 93.90 TIBIA FRACTURE | 1 0.01 93.91 TIC | 1 0.01 93.92 TINEA PEDIS | 1 0.01 93.93 TINNITUS | 9 0.09 94.02 TOBACCO ABUSE | 1 0.01 94.03 TONGUE DISORDER | 1 0.01 94.04 TONGUE ULCERATION | 1 0.01 94.05 TONSILLECTOMY | 2 0.02 94.07 TONSILLITIS | 1 0.01 94.08 TOOTH ABSCESS | 3 0.03 94.11 TOOTH DISORDER | 5 0.05 94.16 TOOTH EXTRACTION | 15 0.15 94.31 TOOTH FRACTURE | 4 0.04 94.35 TOOTH INFECTION | 1 0.01 94.36 TOOTH INJURY | 1 0.01 94.37 TOOTH LOSS | 1 0.01 94.38 TOOTHACHE | 2 0.02 94.40 TORSADE DE POINTES | 1 0.01 94.41 TORTICOLLIS | 1 0.01 94.42 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 94.46 TOXIC SKIN ERUPTION | 3 0.03 94.49 TRACHEAL STENOSIS | 2 0.02 94.51 TRACHEITIS | 1 0.01 94.52 TRACHEO-OESOPHAGEAL FISTULA | 1 0.01 94.53 TRACHEOMALACIA | 2 0.02 94.55 TRANSAMINASES INCREASED | 3 0.03 94.58 TRANSIENT ISCHAEMIC ATTACK | 61 0.61 95.19 TRANSMISSION OF DRUG VIA SEMEN | 2 0.02 95.21 TRANSPLANT REJECTION | 1 0.01 95.22 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 95.23 TREATMENT NONCOMPLIANCE | 7 0.07 95.30 TREATMENT RELATED SECONDARY MALIGNANCY | 1 0.01 95.31 TREMOR | 18 0.18 95.49 TRI-IODOTHYRONINE INCREASED | 1 0.01 95.50 TRICHOMONIASIS | 1 0.01 95.51 TRICUSPID VALVE DISEASE | 1 0.01 95.52 TRICUSPID VALVE INCOMPETENCE | 14 0.14 95.66 TRICUSPID VALVE SCLEROSIS | 1 0.01 95.67 TRIGGER FINGER | 1 0.01 95.68 TRIPLE VESSEL BYPASS GRAFT | 1 0.01 95.69 TROPONIN I INCREASED | 1 0.01 95.70 TUBERCULIN TEST POSITIVE | 1 0.01 95.71 TUBERCULOSIS | 5 0.05 95.76 TUBERCULOUS PLEURISY | 1 0.01 95.77 TUMOUR LYSIS SYNDROME | 1 0.01 95.78 TUNNEL VISION | 1 0.01 95.79 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 95.80 ULCER | 6 0.06 95.86 ULCER HAEMORRHAGE | 5 0.05 95.91 ULNAR NERVE PALSY | 1 0.01 95.92 ULTRASOUND SCAN ABNORMAL | 1 0.01 95.93 UMBILICAL HERNIA | 3 0.03 95.96 UNEVALUABLE EVENT | 4 0.04 96.00 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 96.01 UNRESPONSIVE TO VERBAL STIMULI | 1 0.01 96.02 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 96.06 UPPER LIMB FRACTURE | 2 0.02 96.08 UPPER RESPIRATORY TRACT INFECTION | 15 0.15 96.23 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 96.24 URETERITIS | 1 0.01 96.25 URETHRAL INJURY | 1 0.01 96.26 URINARY INCONTINENCE | 6 0.06 96.32 URINARY RETENTION | 8 0.08 96.40 URINARY TRACT DISORDER | 2 0.02 96.42 URINARY TRACT INFECTION | 25 0.25 96.67 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 96.68 URINE COLOUR ABNORMAL | 1 0.01 96.69 URINE OUTPUT DECREASED | 2 0.02 96.71 UROSEPSIS | 1 0.01 96.72 URTICARIA | 5 0.05 96.77 UTERINE CANCER | 1 0.01 96.78 UTERINE DISORDER | 1 0.01 96.79 UTERINE LEIOMYOMA | 1 0.01 96.80 UVEITIS | 5 0.05 96.85 VAGINAL CANDIDIASIS | 3 0.03 96.88 VAGINAL HAEMORRHAGE | 2 0.02 96.90 VAGINAL PROLAPSE | 1 0.01 96.91 VARICELLA | 1 0.01 96.92 VARICES OESOPHAGEAL | 2 0.02 96.94 VARICOSE VEIN | 3 0.03 96.97 VASCULAR ANOMALY | 1 0.01 96.98 VASCULAR DEMENTIA | 1 0.01 96.99 VASCULAR INSUFFICIENCY | 2 0.02 97.01 VASCULAR OCCLUSION | 1 0.01 97.02 VASCULAR PSEUDOANEURYSM | 1 0.01 97.03 VASCULITIS | 1 0.01 97.04 VASODILATATION | 2 0.02 97.06 VASOSPASM | 1 0.01 97.07 VEIN DISORDER | 1 0.01 97.08 VENOOCCLUSIVE DISEASE | 1 0.01 97.09 VENOUS INSUFFICIENCY | 4 0.04 97.13 VENOUS OCCLUSION | 1 0.01 97.14 VENOUS THROMBOSIS | 2 0.02 97.16 VENTRICULAR ARRHYTHMIA | 4 0.04 97.20 VENTRICULAR DYSFUNCTION | 9 0.09 97.29 VENTRICULAR EXTRASYSTOLES | 10 0.10 97.39 VENTRICULAR FIBRILLATION | 11 0.11 97.50 VENTRICULAR HYPERTROPHY | 15 0.15 97.65 VENTRICULAR HYPOKINESIA | 4 0.04 97.69 VENTRICULAR SEPTAL DEFECT | 3 0.03 97.72 VENTRICULAR TACHYCARDIA | 13 0.13 97.85 VENTRICULO-PERITONEAL SHUNT | 1 0.01 97.86 VERTEBRAL ARTERY OCCLUSION | 1 0.01 97.87 VERTEBRAL INJURY | 3 0.03 97.90 VERTIGO | 13 0.13 98.03 VERTIGO POSITIONAL | 2 0.02 98.05 VESSEL PUNCTURE SITE HAEMORRHAGE | 1 0.01 98.06 VIRAL INFECTION | 3 0.03 98.09 VIRAL LOAD DECREASED | 1 0.01 98.10 VIRAL LOAD INCREASED | 1 0.01 98.11 VIRUS URINE TEST POSITIVE | 1 0.01 98.12 VISION BLURRED | 14 0.14 98.26 VISUAL ACUITY REDUCED | 5 0.05 98.31 VISUAL DISTURBANCE | 19 0.19 98.50 VISUAL FIELD DEFECT | 1 0.01 98.51 VITAL CAPACITY DECREASED | 3 0.03 98.54 VITAMIN B12 DECREASED | 1 0.01 98.55 VITAMIN B12 DEFICIENCY | 2 0.02 98.57 VITREOUS DISORDER | 1 0.01 98.58 VOCAL CORD NEOPLASM | 1 0.01 98.59 VOCAL CORD POLYP | 1 0.01 98.60 VOMITING | 47 0.47 99.07 VULVOVAGINAL DRYNESS | 1 0.01 99.08 WALLENBERG SYNDROME | 1 0.01 99.09 WEIGHT DECREASED | 16 0.16 99.25 WEIGHT FLUCTUATION | 1 0.01 99.26 WEIGHT GAIN POOR | 1 0.01 99.27 WEIGHT INCREASED | 19 0.19 99.46 WHEEZING | 9 0.09 99.55 WHITE BLOOD CELL COUNT DECREASED | 13 0.13 99.68 WHITE BLOOD CELL COUNT INCREASED | 13 0.13 99.81 WHITE BLOOD CELL DISORDER | 1 0.01 99.82 WHOLE BLOOD TRANSFUSION | 1 0.01 99.83 WOUND | 2 0.02 99.85 WOUND DEBRIDEMENT | 2 0.02 99.87 WOUND DRAINAGE | 1 0.01 99.88 WOUND INFECTION | 1 0.01 99.89 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.90 WRIST FRACTURE | 3 0.03 99.93 WRONG DRUG ADMINISTERED | 4 0.04 99.97 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 2 0.02 99.99 X-RAY DENTAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015